US20040015122A1 - Sheath for use with an ultrasound element - Google Patents
Sheath for use with an ultrasound element Download PDFInfo
- Publication number
- US20040015122A1 US20040015122A1 US10/369,271 US36927103A US2004015122A1 US 20040015122 A1 US20040015122 A1 US 20040015122A1 US 36927103 A US36927103 A US 36927103A US 2004015122 A1 US2004015122 A1 US 2004015122A1
- Authority
- US
- United States
- Prior art keywords
- sheath
- drug delivery
- energy
- ultrasound
- section
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000002604 ultrasonography Methods 0.000 title claims abstract description 190
- 238000012377 drug delivery Methods 0.000 claims abstract description 135
- 239000000463 material Substances 0.000 claims abstract description 35
- 229940079593 drug Drugs 0.000 claims description 66
- 239000003814 drug Substances 0.000 claims description 66
- 239000012809 cooling fluid Substances 0.000 claims description 30
- 239000012528 membrane Substances 0.000 claims description 26
- 239000004642 Polyimide Substances 0.000 claims description 9
- 229920001721 polyimide Polymers 0.000 claims description 9
- 230000004044 response Effects 0.000 claims description 7
- 229920001634 Copolyester Polymers 0.000 claims description 4
- 239000000243 solution Substances 0.000 description 41
- 208000007536 Thrombosis Diseases 0.000 description 13
- 238000012545 processing Methods 0.000 description 10
- 238000001816 cooling Methods 0.000 description 7
- 230000033001 locomotion Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 210000001519 tissue Anatomy 0.000 description 6
- 210000004204 blood vessel Anatomy 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920000098 polyolefin Polymers 0.000 description 5
- 230000006378 damage Effects 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 239000004814 polyurethane Substances 0.000 description 4
- 238000002399 angioplasty Methods 0.000 description 3
- 238000009529 body temperature measurement Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000009954 braiding Methods 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 239000003527 fibrinolytic agent Substances 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 229910001006 Constantan Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011091 Coronary artery thrombosis Diseases 0.000 description 1
- 206010051055 Deep vein thrombosis Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920002614 Polyether block amide Polymers 0.000 description 1
- 108010023197 Streptokinase Proteins 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010047249 Venous thrombosis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 208000002528 coronary thrombosis Diseases 0.000 description 1
- 238000011461 current therapy Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 210000003238 esophagus Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000009442 healing mechanism Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000013021 overheating Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000009979 protective mechanism Effects 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229960005202 streptokinase Drugs 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920002725 thermoplastic elastomer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00131—Accessories for endoscopes
- A61B1/00135—Oversleeves mounted on the endoscope prior to insertion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B17/22004—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves
- A61B17/22012—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement
- A61B17/2202—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for using mechanical vibrations, e.g. ultrasonic shock waves in direct contact with, or very close to, the obstruction or concrement the ultrasound transducer being inside patient's body at the distal end of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/12—Diagnosis using ultrasonic, sonic or infrasonic waves in body cavities or body tracts, e.g. by using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/22—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for
- A61B2017/22082—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance
- A61B2017/22084—Implements for squeezing-off ulcers or the like on the inside of inner organs of the body; Implements for scraping-out cavities of body organs, e.g. bones; Calculus removers; Calculus smashing apparatus; Apparatus for removing obstructions in blood vessels, not otherwise provided for after introduction of a substance stone- or thrombus-dissolving
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320068—Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
- A61B2017/320072—Working tips with special features, e.g. extending parts
- A61B2017/320073—Working tips with special features, e.g. extending parts probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/320068—Surgical cutting instruments using mechanical vibrations, e.g. ultrasonic
- A61B2017/320084—Irrigation sleeves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00005—Cooling or heating of the probe or tissue immediately surrounding the probe
- A61B2018/00011—Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
- A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
Definitions
- the present invention relates to an ultrasound enhanced drug delivery apparatus, and more particularly, to an ultrasound element which can be movably positioned within a drug delivery sheath.
- Thrombus formation is a protective and healing mechanism, however, formation of thrombi can be detrimental. For instance, if a blood vessel becomes blocked, distal tissue may be deprived of oxygen with resulting damage or necrosis. In the case of cerebral circulation, an arterial thrombus blockage is one cause of cerebral strokes. In the case of coronary thrombosis, blockage and subsequent distal tissue necrosis of cardiac muscle tissue will impair cardiac pump output, may cause electrical abnormalities, and potentially catastrophic heart failure and death. The thrombus can form at the site of artery narrowing due to arterial wall damage or disease, or the thrombus may have broken free from some proximal site only to become wedged in a distal stenosis. Thrombus can also form subsequent to attempts to remove a stenosis using balloon angioplasty or rotary atherectomy.
- Ultrasound sheaths have been described specifically for removal or dissolution of thrombus (U.S. patents: Tachibana U.S. Pat. No. 5,197,946; Bernstein U.S. Pat. No. 5,163,421; Weng U.S. Pat. No. 5,269,297).
- the sheaths of Bernstein and Weng place an ultrasound generator external to the body and transmit acoustic energy through a metal wire wave-guide to the distal sheath.
- the sheath of Tachibana includes a small ultrasound element positioned at the distal end of the sheath that is energized by electrical wires.
- ultrasound energy is delivered to and radiated from the distal tip of the sheath in the vicinity of a blocking thrombus.
- the application of ultrasound can directly emulsify nearby thrombus through the motion of the sheath tip, associated cavitation, and bioeffects.
- the application of ultrasound can also enhance delivery of drug into a vessel wall.
- the vessel wall is diseased or has been injured during balloon angioplasty or rotary atherectomy. Narrowing of the vessel can occur in response to these injuries.
- Certain drugs, such as heparin may inhibit this narrowing of the blood vessel if the drug can be delivered into the blood vessel wall.
- a sheath can be used to deliver drugs into any portion of the body or target organ. Ultrasound energy in the presence of these drugs can enhance the delivery through and across bodily fluids and tissue.
- an ultrasound drug delivery sheath placed in a blood vessel will assist delivery across the blood vessel wall, whether it be an artery or a vein, into the surrounding muscle or tissue.
- Some thrombi can be large.
- a deep vein thrombus in a patient's lower leg can have a length from several centimeters to as much as 30-50 cm long.
- Early treatment protocols for these long thrombi used a drug infusion sheath to drip lytic drug at one end of a thrombus. As the thrombus was dissolved, the sheath would be advanced. This process was repeated until the entire clot was dissolved.
- More current therapy for a deep vein thrombosis is to use an infusion sheath with drug infusion ports distributed along the lateral dimension of the sheath. The sheath can be pushed through the entire length of the clot. The thrombolytic drug is then infused throughout the lesion for a period of hours.
- a system for delivering ultrasound energy to a treatment section in a vessel includes a sheath with a utility lumen and an energy delivery section at least partially constructed from a material which transmits ultrasound energy.
- the system also includes a drug delivery member having a plurality of drug delivery ports which are positioned adjacent the energy delivery section.
- the system further includes an elongated body including at least one ultrasound element and configured to be movably positioned within the utility lumen to transmit the ultrasound energy from the ultrasound element through the energy delivery section.
- the system in another embodiment includes a sheath having a utility lumen configured to movably receive an elongated body with an ultrasound element and an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element.
- the system also includes a drug delivery member having a plurality of drug delivery ports which are configured to be positioned adjacent the energy delivery section.
- a sheath for delivering ultrasound energy to a treatment section in a vessel is also disclosed.
- the sheath includes a utility lumen configured to movably receive an elongated body with an ultrasound element.
- the sheath also includes an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element.
- a plurality of drug delivery ports are positioned adjacent the energy delivery section.
- the sheath includes a utility lumen configured to movably receive an elongated body with an ultrasound element.
- the sheath also includes an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element.
- At least one temperature sensor is positioned adjacent the energy delivery section.
- a system for delivering ultrasound energy to a treatment section in a vessel includes a sheath having a utility lumen and an energy delivery section which is at least partially constructed from a material which transmits ultrasound energy.
- An expandable balloon positioned at least partially adjacent the energy delivery section.
- the system also includes an elongated body with at least one ultrasound element. The elongated body is configured to be movably positioned within the utility lumen to transmit the ultrasound energy from the ultrasound element through the energy delivery section.
- FIG. 1A is a sideview of a sheath and elongated body according to the present invention.
- FIG. 1B is a sideview of a sheath and elongated body according to the present invention.
- FIG. 2A is a cross section of a sheath with an elongated body positioned within a utility lumen.
- FIG. 2B is a cross section of a sheath proximal end.
- FIG. 2C is a cross section of an elongated body including a body lumen.
- FIG. 2D is a cross section of an elongated body including a body lumen positioned within a sheath including a closed occlusion device.
- FIG. 2E is a cross section of an elongated body including a body lumen positioned within a sheath including a closed occlusion device.
- FIG. 3A is a sideview of a sheath distal end.
- FIG. 3B is a cross sectional view of a sheath distal end.
- FIG. 3C is a sideview of a sheath distal end.
- FIG. 3D is a cross sectional view of a sheath distal end.
- FIG. 3E illustrates a drug delivery member with slit shaped drug delivery ports.
- FIG. 3F illustrates a drug delivery member with arc shaped slits as drug delivery ports.
- FIG. 4A is a sideview of a sheath distal end with drug delivery ports of increasing size.
- FIG. 4B is a is a cross sectional view of a sheath distal end.
- FIG. 5 is a cross section of a sheath distal end with an integral occlusion device.
- FIG. 6A is a sideview of a sheath including a balloon.
- FIG. 6B is a cross section a balloon positioned at a distal end of a sheath which includes drug delivery ports configured to produce an even flow along the length of the energy delivery section.
- FIG. 6C is a cross section of a balloon positioned at a distal end of a sheath which includes an expansion lumen for expanding the balloon and delivering a drug solution.
- FIG. 6D is a cross section of a balloon positioned at a distal end of a sheath which includes an expansion lumen for expanding the balloon and drug delivery ports configured to produce an even flow along the length of the energy delivery section.
- FIG. 7A illustrates ultrasound elements connected in parallel.
- FIG. 7B illustrates ultrasound elements connected in series.
- FIG. 7C illustrates ultrasound elements connected with a common wire.
- FIG. 8 illustrates temperature sensors connected with a common wire.
- FIG. 9 is a block diagram of a feedback control system.
- FIG. 10A is a cross section of a treatment site.
- FIG. 10B is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 10C is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 10D is a sideview of a sheath proximal end.
- FIG. 10E is a cross section of a sheath distal end positioned at a treatment site.
- FIG. 10F illustrates an ultrasound element positioned within a utility lumen.
- FIG. 10G is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 11A illustrates a balloon positioned adjacent a clot.
- FIG. 11B illustrates a balloon expanded into contact with the clot of FIG. 11A.
- the invention relates to a system for delivering ultrasound energy to a treatment section in a vessel.
- the system includes a sheath with an energy delivery section at least partially constructed from a material which transmits ultrasound energy.
- the sheath is designed to be positioned within a vessel such that at least a portion of the energy delivery section is positioned adjacent a treatment site within the vessel.
- the system also includes an elongated body with an ultrasound element positioned at its distal end. The elongated body can be received in a utility lumen included in the sheath such that the ultrasound element is positioned within the energy delivery section. Ultrasound energy can be delivered from the ultrasound element through the energy delivery section to the treatment site.
- the elongated body can be moved within the utility lumen so the ultrasound element can be moved relative to the energy delivery section.
- the ultrasound element can be moved within the treatment site to deliver ultrasound energy to different sections of the treatment site.
- the motion of the ultrasound element relative to the treatment site can help emulsify a clot, thrombus or other blockage at the treatment site. Since, the ultrasound element is being moved relative to the treatment site within the sheath, the movement of the ultrasound element relative to the treatment site does not damage the vessel including the treatment site.
- the elongated body can include a cooling fluid lumen which passes adjacent the ultrasound element.
- a cooling fluid lumen can be formed between the elongated body and the sheath.
- a cooling fluid can be passed through the cooling fluid lumen to cool the ultrasound element.
- the heating of the ultrasound element can limit the amount of power which can be provided to the ultrasound element. Cooling the ultrasound element during its operation allows the power provided to the ultrasound element to be increased. As a result, cooling the ultrasound element can increase the efficiency of the treatment. Movement of the ultrasound element can be accomplished manually or through use of an automated method.
- the system can also include a drug delivery member which includes a plurality of drug delivery ports which are positioned adjacent to the energy delivery section.
- the drug delivery ports permit delivery of a drug solution to the treatment site.
- Ultrasound energy can also be delivered to the treatment site to enhance the effect of the drug within the treatment site.
- the drug delivery member can be external to the energy delivery section. As a result, a drug solution does not need to be delivered through the energy delivery section allowing the energy delivery section to be constructed of acoustically transparent materials which cannot be easily extruded.
- the energy delivery section can also be very thin since a drug delivery lumen need not pass through materials comprising the energy delivery section. Thinner materials increase the acoustic transparency of the energy delivery section. Suitable materials for the energy delivery section include, but are not limited to, polyimides.
- the portion of the sheath which is not included in the energy delivery section can be constructed from materials such as polyurethanes, copolyesters, or thermoplastic elastomers which provides the sheath with kink resistance, rigidity and structural support necessary to transport the energy delivery section to the treatment site.
- the sheath can also include at least one temperature sensor positioned adjacent the energy delivery section.
- the temperature sensors can be coupled with a feedback control system.
- the feedback control system can be used to adjust the level of power delivered to the ultrasound element in response to the signal from at least one temperature sensor. As a result, the temperature at the treatment site can be maintained within a desired range during the treatment.
- FIG. 1A illustrates a drug delivery system 10 according to the present invention.
- the system 10 includes a sheath 12 with a sheath proximal end 14 and a sheath distal end 16 .
- the sheath distal end 16 includes, a support section 17 , an energy delivery section 18 , temperature sensors 20 and an occlusion device 22 .
- the sheath proximal end 14 includes temperature sensor leads 24 and a cooling fluid fitting 26 .
- a utility lumen 28 extends through the sheath 12 along the length of the sheath 12 .
- a drug delivery member 30 is positioned adjacent the energy delivery section.
- the drug delivery member 30 includes a drug inlet port 32 which can be coupled with a drug source via a connector such as a Luer type fitting.
- the drug delivery member 30 can be incorporated into the support section 17 as illustrated in FIG. 1A or can external to the support section as illustrated in FIG. 1B.
- the system 10 also includes an elongated body 34 with a body proximal end 36 and a body distal end 38 .
- An ultrasound element 40 is positioned at the body distal end 38 .
- the elongated body 34 has an outer diameter which permits the elongated body 34 to be inserted into the utility lumen 28 .
- FIG. 2A illustrates the elongated body 34 threaded through the utility lumen 28 until the ultrasound element 40 is positioned within the energy delivery section 18 .
- Suitable outer diameters of the elongated body 34 include, but are not limited to, 0.010′′-0.100′′.
- Suitable diameters of the utility lumen 28 include, but are not limited to 0.015′′-0.110′′.
- the utility lumen 28 extends through the occlusion device 22 .
- the portion of the utility lumen 28 extending through the occlusion device 22 has a diameter which can accommodate a guidewire (not shown) but which prevents the ultrasound element 40 from passing through the occlusion device 22 .
- Suitable inner diameters for the occlusion device 22 include, but are not limited to 0.005′′-0.050′′.
- the ultrasound element 40 can be rotated or moved within the energy delivery section 18 as illustrated by the arrows 52 illustrated in FIG. 2A.
- the movement of the ultrasound element 40 within the energy delivery section 18 can be caused by manipulating the body proximal section while holding the sheath proximal section stationary.
- the elongated body 34 can be at least partially constructed from a material which provides enough structural support to permit movement of the elongated body 34 within the sheath 12 without kinking of the elongated body 34 .
- Suitable materials for the elongated body 34 include, but are not limited to polyesters, polyurethanes, thermoplastic, elastomers.
- the outer diameter of the elongated body 34 can be smaller than the diameter of the utility lumen 28 to create a cooling fluid lumen 44 between the elongated body 34 and the utility lumen 28 .
- a cooling fluid can be flowed through the cooling fluid lumen 44 , past the ultrasound element 40 and through the occlusion device 22 .
- the flowrate of the cooling fluid and/or the power to the ultrasound element 40 can be adjusted to maintain the temperature of the ultrasound element 40 within a desired range.
- the sheath proximal end 14 can include a cap 46 as illustrated in FIG. 2B.
- a cooling fluid can be flowed from the cooling fluid fitting 26 through the cooling fluid lumen 44 as illustrated by the arrows 48 .
- the cap 46 includes a hemostasis valve 50 with an inner diameter which substantially matches the diameter of the elongated body 34 . The matched diameters reduces leaking of the cooling fluid between the cap 46 and the elongated body 34 .
- the ultrasound element 40 can be a hollow cylinder and the elongated body can include a body lumen 51 which extends through the ultrasound element 40 .
- the cooling fluid can be flowed through the body lumen past the ultrasound element 40 to provide cooling to the ultrasound element 40 .
- the occlusion device 22 can be integral with the sheath 12 and can have a closed end.
- the body lumen 51 can serve as a return lumen for the cooling fluid.
- the inside and the outside of the ultrasound element 40 are exposed to the cooling fluid to accelerate the cooling of the ultrasound element 40 .
- the flow of the cooling fluid can be reversed so the cooling lumen serves as the return cooling fluid lumen.
- the above cooling schemes permit the power provided to the ultrasound element to be increased in proportion to the cooling flow rate. Further, certain schemes can prevent exposure of the body to cooling fluids.
- the drug delivery member 30 includes a drug delivery portion which is positioned adjacent the energy delivery section 18 as illustrated in FIG. 3A. As illustrated in FIG. 3B, the drug delivery member 30 includes a drug delivery lumen 56 extending through the length of the drug delivery member 30 . The drug delivery member 30 also includes a series of drug delivery ports 58 coupled with the drug delivery lumen 56 . A drug source coupled with the drug inlet port 32 can provide a pressure which drives a drug solution through the drug delivery lumen 56 and out the drug delivery ports 58 .
- a suitable material for the drug delivery member 30 includes, but is not limited to, polyimide, polyolefin, polyester.
- the sheath 12 can include a plurality of drug delivery members 30 .
- the drug delivery members 30 can be wound around the energy delivery section 18 or they can be positioned along the length of the energy delivery section 18 as illustrated in FIG. 3C.
- Each drug delivery member 30 can be coupled with the same drug inlet port 32 .
- each drug delivery member 30 is coupled with independent drug inlet ports 32 so different drug solutions can be delivered to different drug delivery ports 58 .
- the drug delivery ports 58 are positioned close enough to achieve a substantially even flow of drug solution around the circumference of the energy delivery section 18 and along the length of the energy delivery sections 18 .
- the proximity of adjacent drug delivery ports 58 can be changed by changing the density of drug delivery ports 58 along the drug delivery member, by changing the number of windings of the drug delivery member around the energy delivery section 18 or by changing the number of drug delivery members 30 included adjacent the energy delivery section 18 .
- a suitable displacements between adjacent drug delivery ports 58 include, but are not limited to, from 0.1′′ to 1.0′′, preferable 0.2′′ to 0.6′′.
- the size of the drug delivery ports 58 can be the same or change along the length of the drug delivery member.
- the size of the drug delivery ports 58 distally positioned on the drug delivery section can be larger than the size of the drug delivery ports 58 which are proximally positioned on the drug delivery section.
- the increase in sizes of the drug delivery ports 58 can be designed to produce similar flowrates of drug solution through each drug delivery port 58 . This similar flowrate increases the uniformity of drug solution flowrate along the length of the sheath 12 .
- a suitable size for a drug delivery port 58 includes, but is not limited to 0.0005′′ to 0.0050′′.
- suitable sizes for proximally positioned drug delivery ports 58 includes, but is not limited to from 0.0001′′ to 0.005′′ and suitable sizes for distally positioned drug delivery ports 58 includes, but is not limited to 0.0005′′ to 0.0020′′.
- the increase in size between adjacent drug delivery ports can be substantially uniform between or along the drug delivery member.
- the dimensional increase of the drug delivery ports is dependent upon material and diameter of the drug delivery member.
- the drug delivery ports 58 can be burnt into the drug delivery member 30 with a laser.
- Uniformity of the drug solution flow along the length of the sheath 12 can also be increased by increasing the density of the drug delivery ports 58 toward the distal end of the drug delivery member.
- the drug delivery ports 58 can be slits with a straight shape as illustrated in FIG. 3E or an arcuate shape as illustrated in FIG. 3F.
- the drug delivery member 30 can be constructed from materials such as polyimide, nylon, pebax, polyurethane or silicon.
- the slits close and prevent delivery of additional drug solution.
- the stiffer the material used to construct the drug deliver member the higher the threshold pressure required to open the slit shaped drug delivery ports.
- the slit shape can also prevent the drug delivery ports 58 from opening when exposed to low pressures from outside the sheath 12 . As a result, slit shaped drug delivery ports can maximize control of drug delivery.
- the sheath 12 and energy delivery section 18 can be constructed from a single material as illustrated in FIG. 4A. Suitable materials include, but are not limited to polyimide, polyolefin, polyester. The entire sheath or only the sheath proximal end may be reinforced by braiding, mesh or other constructions to increase flexibility, kink resistance, and pushability. As illustrated in FIG. 4A, the drug delivery ports 58 can be included in the sheath 12 . The drug delivery ports 58 can be coupled with independent drug delivery lumens 28 as illustrated in FIG. 4B.
- the sheath can include a support section 17 which is constructed from a different material than the energy delivery section as illustrated in FIG. 5.
- FIG. 5 also illustrates the occlusion device 22 as being integral with the energy delivery section 18 .
- the energy delivery section 18 can be constructed from a material which readily transmits ultrasound energy.
- the support section can be constructed from a material which provides structural strength and kink resistance. Further, the support section or the proximal end of the support section may be reinforced by braiding, mesh or other constructions to increase flexibility, kink resistance, and pushability.
- Suitable materials for the support section include, but are not limited to, polyimides, polyolefin, polyester.
- a suitable outer diameter for the support section includes, but is not limited to 0.020′′ to 0.200′′.
- Suitable materials for the energy delivery section 18 include, but are not limited to, polyolefins, polyimides, polyester and other low ultrasound impedance materials. Low ultrasound impedance materials are materials which readily transmit ultrasound energy with minimal absorption of the
- the sheath distal end 16 can include a balloon 59 as illustrated in FIG. 6A.
- the balloon 59 can be constructed from permeable membrane or a selectively permeable membrane which allows certain media to flow through the membrane while preventing other media from flowing through the membrane. Suitable materials for the balloon 59 include, but are not limited to cellulose, cellulose acetate, polyvinylchloride, polyolefin, polyurethane and polysulfone.
- the membrane pore sizes are preferably 5 A-2 ⁇ m, more preferably 50 A-900 A and most preferably 100 A-300 A in diameter.
- the balloon 59 can be positioned adjacent drug delivery ports 58 .
- the drug delivery ports 58 can be designed so a uniform flow occurs along the length of the energy delivery section 18 . This design can serve to prevent a pressure gradient from developing along the length of the balloon. Delivering a drug solution through the drug delivery ports 58 can serve to expand the balloon 59 .
- the balloon 59 is constructed from a membrane or a selectively permeable membrane, the drug solution can be delivered with enough pressure to drive the drug across the membrane.
- Various phoretic processes and apparatuses can also be used to drive the drug solution across the membrane.
- the pressure and/or phoresis may drive only certain components of the drug solution across the membrane while preventing other components from crossing the membrane.
- the balloon 59 can also be positioned adjacent one or more expansion ports 60 A coupled with an expansion lumen 60 B as illustrated in FIG. 6C.
- the drug solution can be delivered to the balloon 59 via the expansion-lumen 60 B. Delivering a drug solution through the expansion lumen 60 B can serve to expand the balloon 59 .
- the balloon 59 is constructed from a membrane or a selectively permeable membrane, the drug can be delivered with enough pressure to drive the drug solution or certain components of the drug solution across the membrane.
- phoretic means can also be used to drive the drug solution or certain components of the drug solution across the membrane.
- the balloon 59 can also be positioned adjacent expansion ports 60 A coupled with an expansion lumen 60 B and drug delivery ports 58 as illustrated in FIG. 6D.
- Different drug solutions can be delivered through the expansion ports 60 B and the drug delivery ports 58 .
- a media suitable for expanding the balloon 59 can be delivered through the expansion lumen 60 B and the expansion ports 60 A while the drug solution can be delivered through the drug delivery ports 58 .
- the balloon 59 is constructed from a membrane or a selectively permeable membrane, a medium which wets the membrane and enhances the permeability of the membrane can be delivered through the expansion ports 60 A.
- a drug solution can be delivered through the drug delivery ports 58 concurrently with or after the wetting medium has been delivered.
- the ultrasound energy can be generated at an ultrasound energy source which is remote from the ultrasound elements 40 and transmitted via wire to the ultrasound elements 40 .
- Ultrasound can also be internally generated from electrical power delivered to the ultrasound elements 40 from an electrical energy source.
- a suitable example of an ultrasound element 40 for internal generation of ultrasound energy includes, but is not limited to, piezoelectric ceramic oscillators.
- the ultrasound elements 40 can be shaped as a cylinder, a hollow cylinder and a disk which are concentric with the elongated body 34 .
- the ultrasound elements 40 can also be an array of smaller ultrasound elements 40 or a thin plate positioned within the elongated body 34 .
- a single ultrasound element 40 can be composed of several smaller ultrasound elements 40 . Suitable frequencies for the ultrasound element include, but are not limited to from 20 KHz to 2 MHz.
- Each ultrasound element 40 can each be individually powered.
- the elongated body 34 includes N ultrasound elements 40
- the elongated body 34 must include 2N wires to individually power N ultrasound elements 40 .
- the individual ultrasound elements 40 can also be electrically coupled in serial or in parallel as illustrated in FIGS. 7A and 7B. These arrangements permit maximum flexibility as they require only 2N wires.
- Each of the ultrasound elements 40 receive power simultaneously whether the ultrasound elements 40 are in series or in parallel. When the ultrasound elements 40 are in series, less current is required to produce the same power from each ultrasound element 40 than when the ultrasound elements 40 are connected in parallel. The reduced current allows smaller wires to be used to provide power to the ultrasound elements 40 and accordingly increases the flexibility of the elongated body 34 . When the ultrasound elements 40 are connected in parallel, an ultrasound element 40 can break down and the remaining ultrasound elements 40 will continue to operate.
- a common wire 61 can provide power to each of ultrasound element 40 while each ultrasound element 40 has its own return wire 62 .
- a particular ultrasound element 40 can be individually activated by closing a switch 64 to complete a circuit between the common wire 61 and the particular ultrasound element's return wire 62 . Once a switch 64 corresponding to a particular ultrasound element 40 has been closed, the amount of power supplied to the ultrasound element 40 can be adjusted with the corresponding potentiometer 66 . Accordingly, an elongated body 34 with N ultrasound elements 40 requires only N+1 wires and still permits independent control of the ultrasound elements 40 . This reduced number of wires increases the flexibility of the elongated body 34 .
- the individual return wires 62 can have diameters which are smaller than the common wire 61 diameter.
- the diameter of the individual return wires 62 can be the square root of N times smaller than the diameter of the common wire 61 .
- the system 10 can include at least one temperature sensor 20 .
- Suitable temperature sensors 20 include, but are not limited to, thermistors, thermocouples, resistance temperature detectors (RTD)s, and fiber optic temperature sensors which use thermalchromic liquid crystals.
- Suitable temperature sensor 20 geometries include, but are not limited to, a point, patch, stripe and a band around the sheath 12 .
- the temperature sensors 20 can be positioned on the sheath 12 or on the elongated body 34 near the ultrasound elements 40 .
- the temperature sensors 20 should be positioned so they are exposed to the portion of a treatment section which is receiving drug solution and/or ultrasound energy.
- the temperature sensors 20 can be electrically connected as illustrated in FIG. 8. Each temperature sensor 20 can be coupled with a common wire 61 and then include its own return wire 62 . Accordingly, N+1 wires can be used to independently sense the temperature at the temperature sensors 20 when N temperature sensors 20 are employed.
- a suitable common wire 61 can be constructed from Constantan and suitable return wires 62 can be constructed from copper.
- the temperature at a particular temperature sensor 20 can be determined by closing a switch 64 to complete a circuit between the thermocouple's return wire 62 and the common wire 61 . When the temperature sensors 20 are thermocouples, the temperature can be calculated from the voltage in the circuit.
- the individual return wires 62 can have diameters which are smaller than the common wire 61 diameter.
- Each temperature sensor 20 can also be independently wired.
- Employing N independently wired temperature sensors 20 requires 2N wires to pass the length of the sheath 12 .
- the sheath 12 or elongated body 34 flexibility can also be improved by using fiber optic based temperature sensors 20 .
- the flexibility can be improved because only N fiber optics need to be employed sense the temperature at N temperature sensors 20 .
- the system 10 can be include a feedback control system 68 as illustrated in FIG. 9.
- the temperature at each temperature sensor 20 is monitored and the output power of energy source adjusted accordingly.
- the physician can, if desired, override the closed or open loop system.
- the feedback control system 68 includes an energy source 70 , power circuits 72 and a power calculation device 74 coupled with the ultrasound elements 40 .
- a temperature measurement device 76 is coupled with the temperature sensors 20 on the sheath 12 .
- a processing unit 78 is coupled with the power calculation device 74 , the power circuits 72 and a user interface and display 80 .
- the temperature at each temperature sensor 20 is determined at the temperature measurement device 76 .
- the processing unit 78 receives each determined temperature from the temperature measurement device 76 .
- the determined temperature can then be displayed to the user at the user interface and display 80 .
- the processing unit 78 includes logic for generating a temperature control signal.
- the temperature control signal is proportional to the difference between the measured temperature and a desired temperature.
- the desired temperature can be determined by the user.
- the user can set the predetermined temperature at the user interface and display 80 .
- the temperature control signal is received by the power circuits 72 .
- the power circuits 72 adjust the power level of the energy supplied to the ultrasound elements 40 from the energy source 70 . For instance, when the temperature control signal is above a particular level, the power supplied to a particular ultrasound element 40 is reduced in proportion to the magnitude of the temperature control signal. Similarly, when the temperature control signal is below a particular level, the power supplied to a particular ultrasound element 40 is increased in proportion to the magnitude of the temperature control signal.
- the processing unit 78 monitors the temperature sensors 20 and produces another temperature control signal which is received by the power circuits 72 .
- the processing unit 78 can also include safety control logic.
- the safety control logic detects when the temperature at a temperature sensor 20 has exceeded a safety threshold.
- the processing unit 78 can then provide a temperature control signal which causes the power circuits 72 to stop the delivery of energy from the energy source 70 to the ultrasound elements 40 .
- the ultrasound elements 40 may be mobile relative to the temperature sensors 20 , it can be unclear which ultrasound transducer should have a power level adjustment. As a result, the power level may be identically adjusted at each ultrasound element 40 . Further, the power supplied to each of the ultrasound elements 40 may be adjusted in response to the temperature sensor 20 which indicates the highest temperature. Making power adjustments in response to the temperature of the temperature sensor 20 indicating the highest temperature can prevent overheating of the treatment site.
- the processing unit 78 also receives a power signal from a power calculation device 74 .
- the power signal can be used to determine the power being received by each ultrasound element 40 .
- the determined power can then be displayed to the user on the user interface and display 80 .
- the feedback control system 68 can maintain the tissue adjacent to the ultrasound elements 40 at a desired temperature for a selected period of time.
- the ultrasound elements 40 can be electrically connected so each ultrasound element 40 can generate an independent output. The output maintains a selected energy at each ultrasound element 40 for a selected length of time.
- the processing unit 78 can be a digital or analog controller, or a computer with software. When the processing unit 78 is a computer it can include a CPU coupled through a system bus.
- the user interface and display 80 can be a mouse, keyboard, a disk drive, or other non-volatile memory systems, a display monitor, and other peripherals, as are known in the art. Also coupled to the bus is a program memory and a data memory.
- a profile of the power delivered to each ultrasound element 40 can be incorporated in the processing unit 78 and a preset amount of energy to be delivered may also be profiled.
- the power delivered to each ultrasound element 40 can the be adjusted according to the profiles.
- FIGS. 10 A- 10 G illustrate a method for using the system 10 .
- a guidewire 84 similar to a to a guidewire used in typical angioplasty procedures is directed through vessels 86 toward a treatment site 88 which includes a clot 90 .
- the guidewire 84 is directed through the clot 90 .
- Suitable vessels include, but are not limited to, cardiovascular vessels, the pancreas, sinuses, esophagus, rectum, gastrointestinal vessels and urological vessels.
- the utility lumen 28 of the sheath 12 is slid over the guidewire 84 and the sheath 12 is advanced along the guidewire 84 using traditional over-the-guidewire techniques.
- the sheath 12 is advanced until the energy delivery section 18 of the sheath 12 is positioned at the clot 90 .
- Radio opaque markers may be positioned at the energy delivery section 18 of the sheath 12 to aid in the positioning of the sheath 12 within the treatment site 88 .
- the guidewire 84 is withdrawn from the utility lumen 28 by pulling the guidewire 84 proximally while holding the sheath 12 stationary.
- a temperature monitor 92 is coupled with the temperature sensor leads 24
- a cooling fluid source 94 is coupled with the cooling fluid inlet
- a drug solution source 96 is coupled with the drug inlet port 32 .
- the drug solution source 96 can be a syringe with a Luer fitting which is complementary with the drug inlet port 32 . Pressure can be applied to a plunger 98 on the drug solution source 96 to drive the drug solution through the drug delivery lumen 56 .
- Suitable drug solutions include, but are not limited to, an aqueous solution containing Heparin, Uronkinase, Streptokinase, or tissue Plasminogen Activator (TPA).
- the elongated body 34 is inserted into the utility lumen 28 until the ultrasound element 40 is positioned within the energy delivery section 18 .
- radiopaque markers may be positioned on the elongated body 34 adjacent to each of the ultrasound elements 40 .
- the ultrasound elements 40 themselves can be radiopaque.
- the movement of the ultrasound element 40 within the energy delivery section 18 can be caused by manipulating the body proximal section while holding the sheath proximal section stationary.
- a cooling fluid is flowed through the cooling fluid lumen 44 and out the occlusion device 22 .
- the cooling fluid can be delivered before, after, during or intermittently with the delivery of the ultrasound energy.
- the drug solution can be delivered before, after, during or intermittently to the delivery of ultrasound energy.
- FIGS. 10 A- 10 F can be performed in different orders than are described above.
- the drug solution and energy are applied until the clot 90 is partially or entirely dissolved as illustrated in FIG. 10G. Once the clot 90 has been dissolved to the desired degree, the sheath 12 and elongated body 34 are withdrawn from the treatment site 88 .
- FIGS. 11 A- 11 B illustrate a method for using the system 10 when the sheath distal end 16 includes a balloon 59 .
- the sheath 12 is, advanced through a vessel 86 , as described above, until the balloon 59 is positioned adjacent a clot 90 as illustrated in FIG. 11A.
- the balloon 59 is expanded until the balloon 59 contacts the clot 90 as illustrated in FIG. 11B.
- the balloon 59 can be expanded by delivering a drug solution through an expansion port 60 A or a drug delivery port 58 or by delivering an expansion media through an expansion port 60 A.
- the drug solution or components of the drug solution are driven across the membrane so the drug solution or the components of the drug solution contact the clot 90 .
- the elongated body 34 can be inserted into the sheath 12 before, after or concurrently with the expansion of the balloon 59 and/or the delivery of the drug solution.
- the ultrasound element 40 can be operated before, after, intermittently or concurrently with the expansion of the balloon 59 and/or the delivery of the drug solution.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biophysics (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Optics & Photonics (AREA)
- Dermatology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- Dentistry (AREA)
Abstract
Description
- 1. Field of the Invention
- The present invention relates to an ultrasound enhanced drug delivery apparatus, and more particularly, to an ultrasound element which can be movably positioned within a drug delivery sheath.
- 2. Description of Related Art
- Thrombus formation is a protective and healing mechanism, however, formation of thrombi can be detrimental. For instance, if a blood vessel becomes blocked, distal tissue may be deprived of oxygen with resulting damage or necrosis. In the case of cerebral circulation, an arterial thrombus blockage is one cause of cerebral strokes. In the case of coronary thrombosis, blockage and subsequent distal tissue necrosis of cardiac muscle tissue will impair cardiac pump output, may cause electrical abnormalities, and potentially catastrophic heart failure and death. The thrombus can form at the site of artery narrowing due to arterial wall damage or disease, or the thrombus may have broken free from some proximal site only to become wedged in a distal stenosis. Thrombus can also form subsequent to attempts to remove a stenosis using balloon angioplasty or rotary atherectomy.
- Ultrasound sheaths have been described specifically for removal or dissolution of thrombus (U.S. patents: Tachibana U.S. Pat. No. 5,197,946; Bernstein U.S. Pat. No. 5,163,421; Weng U.S. Pat. No. 5,269,297). The sheaths of Bernstein and Weng place an ultrasound generator external to the body and transmit acoustic energy through a metal wire wave-guide to the distal sheath. The sheath of Tachibana includes a small ultrasound element positioned at the distal end of the sheath that is energized by electrical wires. In either case, ultrasound energy is delivered to and radiated from the distal tip of the sheath in the vicinity of a blocking thrombus. The application of ultrasound can directly emulsify nearby thrombus through the motion of the sheath tip, associated cavitation, and bioeffects.
- The application of ultrasound can also enhance delivery of drug into a vessel wall. There are instances where the vessel wall is diseased or has been injured during balloon angioplasty or rotary atherectomy. Narrowing of the vessel can occur in response to these injuries. Certain drugs, such as heparin, may inhibit this narrowing of the blood vessel if the drug can be delivered into the blood vessel wall. A sheath can be used to deliver drugs into any portion of the body or target organ. Ultrasound energy in the presence of these drugs can enhance the delivery through and across bodily fluids and tissue. Hence, an ultrasound drug delivery sheath placed in a blood vessel will assist delivery across the blood vessel wall, whether it be an artery or a vein, into the surrounding muscle or tissue.
- The intensity of the ultrasound delivered from a cylindrical ultrasound element decreases exponentially with radial distance from the sheath tip. Hence, treatment of thrombi is limited to the circumferential area surrounding of the sheath tip of a sheath with an ultrasound element. This limited treatment area may be effective for small length clots, however, larger clots must be treated one section at a time.
- Some thrombi can be large. For instance, a deep vein thrombus in a patient's lower leg and can have a length from several centimeters to as much as 30-50 cm long. Early treatment protocols for these long thrombi used a drug infusion sheath to drip lytic drug at one end of a thrombus. As the thrombus was dissolved, the sheath would be advanced. This process was repeated until the entire clot was dissolved. More current therapy for a deep vein thrombosis is to use an infusion sheath with drug infusion ports distributed along the lateral dimension of the sheath. The sheath can be pushed through the entire length of the clot. The thrombolytic drug is then infused throughout the lesion for a period of hours.
- There is a need for an ultrasound sheath that is useful for treating a deep vein thrombus to enhance and accelerate the action of the thrombolytic drug. There is a further need for an ultrasound sheath that is useful for treating vessel lesions, particularly those that have extensive lengths.
- A system for delivering ultrasound energy to a treatment section in a vessel is disclosed. The system includes a sheath with a utility lumen and an energy delivery section at least partially constructed from a material which transmits ultrasound energy. The system also includes a drug delivery member having a plurality of drug delivery ports which are positioned adjacent the energy delivery section. The system further includes an elongated body including at least one ultrasound element and configured to be movably positioned within the utility lumen to transmit the ultrasound energy from the ultrasound element through the energy delivery section.
- In another embodiment the system includes a sheath having a utility lumen configured to movably receive an elongated body with an ultrasound element and an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element. The system also includes a drug delivery member having a plurality of drug delivery ports which are configured to be positioned adjacent the energy delivery section.
- A sheath for delivering ultrasound energy to a treatment section in a vessel is also disclosed. The sheath includes a utility lumen configured to movably receive an elongated body with an ultrasound element. The sheath also includes an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element. A plurality of drug delivery ports are positioned adjacent the energy delivery section.
- In another embodiment, the sheath includes a utility lumen configured to movably receive an elongated body with an ultrasound element. The sheath also includes an energy delivery section at least partially constructed from a material which transmits ultrasound energy from the ultrasound element. At least one temperature sensor is positioned adjacent the energy delivery section.
- A system for delivering ultrasound energy to a treatment section in a vessel is disclosed. The system includes a sheath having a utility lumen and an energy delivery section which is at least partially constructed from a material which transmits ultrasound energy. An expandable balloon positioned at least partially adjacent the energy delivery section. The system also includes an elongated body with at least one ultrasound element. The elongated body is configured to be movably positioned within the utility lumen to transmit the ultrasound energy from the ultrasound element through the energy delivery section.
- FIG. 1A is a sideview of a sheath and elongated body according to the present invention.
- FIG. 1B is a sideview of a sheath and elongated body according to the present invention.
- FIG. 2A is a cross section of a sheath with an elongated body positioned within a utility lumen.
- FIG. 2B is a cross section of a sheath proximal end.
- FIG. 2C is a cross section of an elongated body including a body lumen.
- FIG. 2D is a cross section of an elongated body including a body lumen positioned within a sheath including a closed occlusion device.
- FIG. 2E is a cross section of an elongated body including a body lumen positioned within a sheath including a closed occlusion device.
- FIG. 3A is a sideview of a sheath distal end.
- FIG. 3B is a cross sectional view of a sheath distal end.
- FIG. 3C is a sideview of a sheath distal end.
- FIG. 3D is a cross sectional view of a sheath distal end.
- FIG. 3E illustrates a drug delivery member with slit shaped drug delivery ports.
- FIG. 3F illustrates a drug delivery member with arc shaped slits as drug delivery ports.
- FIG. 4A is a sideview of a sheath distal end with drug delivery ports of increasing size.
- FIG. 4B is a is a cross sectional view of a sheath distal end.
- FIG. 5 is a cross section of a sheath distal end with an integral occlusion device.
- FIG. 6A is a sideview of a sheath including a balloon.
- FIG. 6B is a cross section a balloon positioned at a distal end of a sheath which includes drug delivery ports configured to produce an even flow along the length of the energy delivery section.
- FIG. 6C is a cross section of a balloon positioned at a distal end of a sheath which includes an expansion lumen for expanding the balloon and delivering a drug solution.
- FIG. 6D is a cross section of a balloon positioned at a distal end of a sheath which includes an expansion lumen for expanding the balloon and drug delivery ports configured to produce an even flow along the length of the energy delivery section.
- FIG. 7A illustrates ultrasound elements connected in parallel.
- FIG. 7B illustrates ultrasound elements connected in series.
- FIG. 7C illustrates ultrasound elements connected with a common wire.
- FIG. 8 illustrates temperature sensors connected with a common wire.
- FIG. 9 is a block diagram of a feedback control system.
- FIG. 10A is a cross section of a treatment site.
- FIG. 10B is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 10C is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 10D is a sideview of a sheath proximal end.
- FIG. 10E is a cross section of a sheath distal end positioned at a treatment site.
- FIG. 10F illustrates an ultrasound element positioned within a utility lumen.
- FIG. 10G is a sideview of a sheath distal end positioned at a treatment site.
- FIG. 11A illustrates a balloon positioned adjacent a clot.
- FIG. 11B illustrates a balloon expanded into contact with the clot of FIG. 11A.
- The invention relates to a system for delivering ultrasound energy to a treatment section in a vessel. The system includes a sheath with an energy delivery section at least partially constructed from a material which transmits ultrasound energy. The sheath is designed to be positioned within a vessel such that at least a portion of the energy delivery section is positioned adjacent a treatment site within the vessel. The system also includes an elongated body with an ultrasound element positioned at its distal end. The elongated body can be received in a utility lumen included in the sheath such that the ultrasound element is positioned within the energy delivery section. Ultrasound energy can be delivered from the ultrasound element through the energy delivery section to the treatment site.
- The elongated body can be moved within the utility lumen so the ultrasound element can be moved relative to the energy delivery section. As a result, the ultrasound element can be moved within the treatment site to deliver ultrasound energy to different sections of the treatment site. The motion of the ultrasound element relative to the treatment site can help emulsify a clot, thrombus or other blockage at the treatment site. Since, the ultrasound element is being moved relative to the treatment site within the sheath, the movement of the ultrasound element relative to the treatment site does not damage the vessel including the treatment site.
- The elongated body can include a cooling fluid lumen which passes adjacent the ultrasound element. Similarly, a cooling fluid lumen can be formed between the elongated body and the sheath. A cooling fluid can be passed through the cooling fluid lumen to cool the ultrasound element. The heating of the ultrasound element can limit the amount of power which can be provided to the ultrasound element. Cooling the ultrasound element during its operation allows the power provided to the ultrasound element to be increased. As a result, cooling the ultrasound element can increase the efficiency of the treatment. Movement of the ultrasound element can be accomplished manually or through use of an automated method.
- The system can also include a drug delivery member which includes a plurality of drug delivery ports which are positioned adjacent to the energy delivery section. The drug delivery ports permit delivery of a drug solution to the treatment site. Ultrasound energy can also be delivered to the treatment site to enhance the effect of the drug within the treatment site.
- The drug delivery member can be external to the energy delivery section. As a result, a drug solution does not need to be delivered through the energy delivery section allowing the energy delivery section to be constructed of acoustically transparent materials which cannot be easily extruded. The energy delivery section can also be very thin since a drug delivery lumen need not pass through materials comprising the energy delivery section. Thinner materials increase the acoustic transparency of the energy delivery section. Suitable materials for the energy delivery section include, but are not limited to, polyimides. The portion of the sheath which is not included in the energy delivery section can be constructed from materials such as polyurethanes, copolyesters, or thermoplastic elastomers which provides the sheath with kink resistance, rigidity and structural support necessary to transport the energy delivery section to the treatment site.
- The sheath can also include at least one temperature sensor positioned adjacent the energy delivery section. The temperature sensors can be coupled with a feedback control system. The feedback control system can be used to adjust the level of power delivered to the ultrasound element in response to the signal from at least one temperature sensor. As a result, the temperature at the treatment site can be maintained within a desired range during the treatment.
- FIG. 1A illustrates a
drug delivery system 10 according to the present invention. Thesystem 10 includes asheath 12 with a sheathproximal end 14 and a sheathdistal end 16. The sheathdistal end 16 includes, asupport section 17, anenergy delivery section 18,temperature sensors 20 and anocclusion device 22. The sheathproximal end 14 includes temperature sensor leads 24 and a coolingfluid fitting 26. Autility lumen 28 extends through thesheath 12 along the length of thesheath 12. Adrug delivery member 30 is positioned adjacent the energy delivery section. Thedrug delivery member 30 includes adrug inlet port 32 which can be coupled with a drug source via a connector such as a Luer type fitting. Thedrug delivery member 30 can be incorporated into thesupport section 17 as illustrated in FIG. 1A or can external to the support section as illustrated in FIG. 1B. Thesystem 10 also includes anelongated body 34 with a bodyproximal end 36 and a bodydistal end 38. Anultrasound element 40 is positioned at the bodydistal end 38. - The elongated
body 34 has an outer diameter which permits theelongated body 34 to be inserted into theutility lumen 28. FIG. 2A illustrates theelongated body 34 threaded through theutility lumen 28 until theultrasound element 40 is positioned within theenergy delivery section 18. Suitable outer diameters of theelongated body 34 include, but are not limited to, 0.010″-0.100″. Suitable diameters of theutility lumen 28 include, but are not limited to 0.015″-0.110″. Theutility lumen 28 extends through theocclusion device 22. The portion of theutility lumen 28 extending through theocclusion device 22 has a diameter which can accommodate a guidewire (not shown) but which prevents theultrasound element 40 from passing through theocclusion device 22. Suitable inner diameters for theocclusion device 22 include, but are not limited to 0.005″-0.050″. - The
ultrasound element 40 can be rotated or moved within theenergy delivery section 18 as illustrated by the arrows 52 illustrated in FIG. 2A. The movement of theultrasound element 40 within theenergy delivery section 18 can be caused by manipulating the body proximal section while holding the sheath proximal section stationary. Theelongated body 34 can be at least partially constructed from a material which provides enough structural support to permit movement of theelongated body 34 within thesheath 12 without kinking of theelongated body 34. Suitable materials for theelongated body 34 include, but are not limited to polyesters, polyurethanes, thermoplastic, elastomers. - As illustrated in FIG. 2A, the outer diameter of the
elongated body 34 can be smaller than the diameter of theutility lumen 28 to create a coolingfluid lumen 44 between theelongated body 34 and theutility lumen 28. A cooling fluid can be flowed through the coolingfluid lumen 44, past theultrasound element 40 and through theocclusion device 22. The flowrate of the cooling fluid and/or the power to theultrasound element 40 can be adjusted to maintain the temperature of theultrasound element 40 within a desired range. - The sheath
proximal end 14 can include acap 46 as illustrated in FIG. 2B. A cooling fluid can be flowed from the coolingfluid fitting 26 through the coolingfluid lumen 44 as illustrated by thearrows 48. Thecap 46 includes ahemostasis valve 50 with an inner diameter which substantially matches the diameter of theelongated body 34. The matched diameters reduces leaking of the cooling fluid between thecap 46 and theelongated body 34. - As illustrated in FIG. 2C, the
ultrasound element 40 can be a hollow cylinder and the elongated body can include abody lumen 51 which extends through theultrasound element 40. The cooling fluid can be flowed through the body lumen past theultrasound element 40 to provide cooling to theultrasound element 40. - As illustrated in FIG. 2D, the
occlusion device 22 can be integral with thesheath 12 and can have a closed end. The body lumen 51 can serve as a return lumen for the cooling fluid. As a result, the inside and the outside of theultrasound element 40 are exposed to the cooling fluid to accelerate the cooling of theultrasound element 40. As illustrated in FIG. 2D, the flow of the cooling fluid can be reversed so the cooling lumen serves as the return cooling fluid lumen. The above cooling schemes permit the power provided to the ultrasound element to be increased in proportion to the cooling flow rate. Further, certain schemes can prevent exposure of the body to cooling fluids. - The
drug delivery member 30 includes a drug delivery portion which is positioned adjacent theenergy delivery section 18 as illustrated in FIG. 3A. As illustrated in FIG. 3B, thedrug delivery member 30 includes adrug delivery lumen 56 extending through the length of thedrug delivery member 30. Thedrug delivery member 30 also includes a series ofdrug delivery ports 58 coupled with thedrug delivery lumen 56. A drug source coupled with thedrug inlet port 32 can provide a pressure which drives a drug solution through thedrug delivery lumen 56 and out thedrug delivery ports 58. A suitable material for thedrug delivery member 30 includes, but is not limited to, polyimide, polyolefin, polyester. - The
sheath 12 can include a plurality ofdrug delivery members 30. Thedrug delivery members 30 can be wound around theenergy delivery section 18 or they can be positioned along the length of theenergy delivery section 18 as illustrated in FIG. 3C. Eachdrug delivery member 30 can be coupled with the samedrug inlet port 32. In another embodiment, eachdrug delivery member 30 is coupled with independentdrug inlet ports 32 so different drug solutions can be delivered to differentdrug delivery ports 58. - The
drug delivery ports 58 are positioned close enough to achieve a substantially even flow of drug solution around the circumference of theenergy delivery section 18 and along the length of theenergy delivery sections 18. The proximity of adjacentdrug delivery ports 58 can be changed by changing the density ofdrug delivery ports 58 along the drug delivery member, by changing the number of windings of the drug delivery member around theenergy delivery section 18 or by changing the number ofdrug delivery members 30 included adjacent theenergy delivery section 18. A suitable displacements between adjacentdrug delivery ports 58 include, but are not limited to, from 0.1″ to 1.0″, preferable 0.2″ to 0.6″. - The size of the
drug delivery ports 58 can be the same or change along the length of the drug delivery member. For instance, the size of thedrug delivery ports 58 distally positioned on the drug delivery section can be larger than the size of thedrug delivery ports 58 which are proximally positioned on the drug delivery section. The increase in sizes of thedrug delivery ports 58 can be designed to produce similar flowrates of drug solution through eachdrug delivery port 58. This similar flowrate increases the uniformity of drug solution flowrate along the length of thesheath 12. When thedrug delivery ports 58 have similar sizes along the length of the drug delivery member, a suitable size for adrug delivery port 58 includes, but is not limited to 0.0005″ to 0.0050″. When the size of thedrug delivery ports 58 changes along the length of the drug delivery member, suitable sizes for proximally positioneddrug delivery ports 58 includes, but is not limited to from 0.0001″ to 0.005″ and suitable sizes for distally positioneddrug delivery ports 58 includes, but is not limited to 0.0005″ to 0.0020″. The increase in size between adjacent drug delivery ports can be substantially uniform between or along the drug delivery member. The dimensional increase of the drug delivery ports is dependent upon material and diameter of the drug delivery member. Thedrug delivery ports 58 can be burnt into thedrug delivery member 30 with a laser. - Uniformity of the drug solution flow along the length of the
sheath 12 can also be increased by increasing the density of thedrug delivery ports 58 toward the distal end of the drug delivery member. - The
drug delivery ports 58 can be slits with a straight shape as illustrated in FIG. 3E or an arcuate shape as illustrated in FIG. 3F. Thedrug delivery member 30 can be constructed from materials such as polyimide, nylon, pebax, polyurethane or silicon. When the dugdelivery lumen 56 is filled with drug solution, the slits remain closed until the pressure within the drug delivery lumen exceeds a threshold pressure. As the pressure within the drug delivery lumen builds, the pressure on each of the slits will be approximately uniform. Once, the threshold pressure is reached, the uniform pressure will result in the slits opening almost simultaneously and cause a nearly uniform flow of drug solution out of all the slits. When the pressure within thedrug delivery lumen 56 falls below the threshold pressure, the slits close and prevent delivery of additional drug solution. The stiffer the material used to construct the drug deliver member, the higher the threshold pressure required to open the slit shaped drug delivery ports. The slit shape can also prevent thedrug delivery ports 58 from opening when exposed to low pressures from outside thesheath 12. As a result, slit shaped drug delivery ports can maximize control of drug delivery. - The
sheath 12 andenergy delivery section 18 can be constructed from a single material as illustrated in FIG. 4A. Suitable materials include, but are not limited to polyimide, polyolefin, polyester. The entire sheath or only the sheath proximal end may be reinforced by braiding, mesh or other constructions to increase flexibility, kink resistance, and pushability. As illustrated in FIG. 4A, thedrug delivery ports 58 can be included in thesheath 12. Thedrug delivery ports 58 can be coupled with independentdrug delivery lumens 28 as illustrated in FIG. 4B. - The sheath can include a
support section 17 which is constructed from a different material than the energy delivery section as illustrated in FIG. 5. FIG. 5 also illustrates theocclusion device 22 as being integral with theenergy delivery section 18. Theenergy delivery section 18 can be constructed from a material which readily transmits ultrasound energy. The support section can be constructed from a material which provides structural strength and kink resistance. Further, the support section or the proximal end of the support section may be reinforced by braiding, mesh or other constructions to increase flexibility, kink resistance, and pushability. Suitable materials for the support section include, but are not limited to, polyimides, polyolefin, polyester. A suitable outer diameter for the support section includes, but is not limited to 0.020″ to 0.200″. Suitable materials for theenergy delivery section 18 include, but are not limited to, polyolefins, polyimides, polyester and other low ultrasound impedance materials. Low ultrasound impedance materials are materials which readily transmit ultrasound energy with minimal absorption of the ultrasound energy. - The sheath
distal end 16 can include aballoon 59 as illustrated in FIG. 6A. Theballoon 59 can be constructed from permeable membrane or a selectively permeable membrane which allows certain media to flow through the membrane while preventing other media from flowing through the membrane. Suitable materials for theballoon 59 include, but are not limited to cellulose, cellulose acetate, polyvinylchloride, polyolefin, polyurethane and polysulfone. When the balloon is constructed from a permeable membrane or a selectively permeable membrane, the membrane pore sizes are preferably 5 A-2 μm, more preferably 50 A-900 A and most preferably 100 A-300 A in diameter. - As illustrated in FIGS.6B, the
balloon 59 can be positioned adjacentdrug delivery ports 58. Thedrug delivery ports 58 can be designed so a uniform flow occurs along the length of theenergy delivery section 18. This design can serve to prevent a pressure gradient from developing along the length of the balloon. Delivering a drug solution through thedrug delivery ports 58 can serve to expand theballoon 59. When theballoon 59 is constructed from a membrane or a selectively permeable membrane, the drug solution can be delivered with enough pressure to drive the drug across the membrane. Various phoretic processes and apparatuses can also be used to drive the drug solution across the membrane. When theballoon 59 is constructed from a selectively permeable membrane, the pressure and/or phoresis may drive only certain components of the drug solution across the membrane while preventing other components from crossing the membrane. - The
balloon 59 can also be positioned adjacent one ormore expansion ports 60A coupled with an expansion lumen 60B as illustrated in FIG. 6C. The drug solution can be delivered to theballoon 59 via the expansion-lumen 60B. Delivering a drug solution through the expansion lumen 60B can serve to expand theballoon 59. When theballoon 59 is constructed from a membrane or a selectively permeable membrane, the drug can be delivered with enough pressure to drive the drug solution or certain components of the drug solution across the membrane. Similarly, phoretic means can also be used to drive the drug solution or certain components of the drug solution across the membrane. - The
balloon 59 can also be positionedadjacent expansion ports 60A coupled with an expansion lumen 60B anddrug delivery ports 58 as illustrated in FIG. 6D. Different drug solutions can be delivered through the expansion ports 60B and thedrug delivery ports 58. Further, a media suitable for expanding theballoon 59 can be delivered through the expansion lumen 60B and theexpansion ports 60A while the drug solution can be delivered through thedrug delivery ports 58. When theballoon 59 is constructed from a membrane or a selectively permeable membrane, a medium which wets the membrane and enhances the permeability of the membrane can be delivered through theexpansion ports 60A. A drug solution can be delivered through thedrug delivery ports 58 concurrently with or after the wetting medium has been delivered. - The ultrasound energy can be generated at an ultrasound energy source which is remote from the
ultrasound elements 40 and transmitted via wire to theultrasound elements 40. Ultrasound can also be internally generated from electrical power delivered to theultrasound elements 40 from an electrical energy source. A suitable example of anultrasound element 40 for internal generation of ultrasound energy includes, but is not limited to, piezoelectric ceramic oscillators. Theultrasound elements 40 can be shaped as a cylinder, a hollow cylinder and a disk which are concentric with theelongated body 34. Theultrasound elements 40 can also be an array ofsmaller ultrasound elements 40 or a thin plate positioned within theelongated body 34. Similarly, asingle ultrasound element 40 can be composed of severalsmaller ultrasound elements 40. Suitable frequencies for the ultrasound element include, but are not limited to from 20 KHz to 2 MHz. - Each
ultrasound element 40 can each be individually powered. When theelongated body 34 includesN ultrasound elements 40, theelongated body 34 must include 2N wires to individually powerN ultrasound elements 40. Theindividual ultrasound elements 40 can also be electrically coupled in serial or in parallel as illustrated in FIGS. 7A and 7B. These arrangements permit maximum flexibility as they require only 2N wires. Each of theultrasound elements 40 receive power simultaneously whether theultrasound elements 40 are in series or in parallel. When theultrasound elements 40 are in series, less current is required to produce the same power from eachultrasound element 40 than when theultrasound elements 40 are connected in parallel. The reduced current allows smaller wires to be used to provide power to theultrasound elements 40 and accordingly increases the flexibility of theelongated body 34. When theultrasound elements 40 are connected in parallel, anultrasound element 40 can break down and the remainingultrasound elements 40 will continue to operate. - As illustrated in FIG. 7C, a
common wire 61 can provide power to each ofultrasound element 40 while eachultrasound element 40 has itsown return wire 62. Aparticular ultrasound element 40 can be individually activated by closing aswitch 64 to complete a circuit between thecommon wire 61 and the particular ultrasound element'sreturn wire 62. Once aswitch 64 corresponding to aparticular ultrasound element 40 has been closed, the amount of power supplied to theultrasound element 40 can be adjusted with the correspondingpotentiometer 66. Accordingly, anelongated body 34 withN ultrasound elements 40 requires only N+1 wires and still permits independent control of theultrasound elements 40. This reduced number of wires increases the flexibility of theelongated body 34. To improve the flexibility of theelongated body 34, theindividual return wires 62 can have diameters which are smaller than thecommon wire 61 diameter. For instance, in an embodiment whereN ultrasound elements 40 will be powered simultaneously, the diameter of theindividual return wires 62 can be the square root of N times smaller than the diameter of thecommon wire 61. - As illustrated in FIG. 1, the
system 10 can include at least onetemperature sensor 20.Suitable temperature sensors 20 include, but are not limited to, thermistors, thermocouples, resistance temperature detectors (RTD)s, and fiber optic temperature sensors which use thermalchromic liquid crystals.Suitable temperature sensor 20 geometries include, but are not limited to, a point, patch, stripe and a band around thesheath 12. Thetemperature sensors 20 can be positioned on thesheath 12 or on theelongated body 34 near theultrasound elements 40. Thetemperature sensors 20 should be positioned so they are exposed to the portion of a treatment section which is receiving drug solution and/or ultrasound energy. - The
temperature sensors 20 can be electrically connected as illustrated in FIG. 8. Eachtemperature sensor 20 can be coupled with acommon wire 61 and then include itsown return wire 62. Accordingly, N+1 wires can be used to independently sense the temperature at thetemperature sensors 20 whenN temperature sensors 20 are employed. A suitablecommon wire 61 can be constructed from Constantan andsuitable return wires 62 can be constructed from copper. The temperature at aparticular temperature sensor 20 can be determined by closing aswitch 64 to complete a circuit between the thermocouple'sreturn wire 62 and thecommon wire 61. When thetemperature sensors 20 are thermocouples, the temperature can be calculated from the voltage in the circuit. To improve the flexibility of thesheath 12, theindividual return wires 62 can have diameters which are smaller than thecommon wire 61 diameter. - Each
temperature sensor 20 can also be independently wired. Employing N independently wiredtemperature sensors 20 requires 2N wires to pass the length of thesheath 12. - The
sheath 12 orelongated body 34 flexibility can also be improved by using fiber optic basedtemperature sensors 20. The flexibility can be improved because only N fiber optics need to be employed sense the temperature atN temperature sensors 20. - The
system 10 can be include a feedback control system 68 as illustrated in FIG. 9. The temperature at eachtemperature sensor 20 is monitored and the output power of energy source adjusted accordingly. The physician can, if desired, override the closed or open loop system. - The feedback control system68 includes an
energy source 70,power circuits 72 and apower calculation device 74 coupled with theultrasound elements 40. Atemperature measurement device 76 is coupled with thetemperature sensors 20 on thesheath 12. Aprocessing unit 78 is coupled with thepower calculation device 74, thepower circuits 72 and a user interface anddisplay 80. - In operation, the temperature at each
temperature sensor 20 is determined at thetemperature measurement device 76. Theprocessing unit 78 receives each determined temperature from thetemperature measurement device 76. The determined temperature can then be displayed to the user at the user interface anddisplay 80. - The
processing unit 78 includes logic for generating a temperature control signal. The temperature control signal is proportional to the difference between the measured temperature and a desired temperature. The desired temperature can be determined by the user. The user can set the predetermined temperature at the user interface anddisplay 80. - The temperature control signal is received by the
power circuits 72. Thepower circuits 72 adjust the power level of the energy supplied to theultrasound elements 40 from theenergy source 70. For instance, when the temperature control signal is above a particular level, the power supplied to aparticular ultrasound element 40 is reduced in proportion to the magnitude of the temperature control signal. Similarly, when the temperature control signal is below a particular level, the power supplied to aparticular ultrasound element 40 is increased in proportion to the magnitude of the temperature control signal. After each power adjustment, theprocessing unit 78 monitors thetemperature sensors 20 and produces another temperature control signal which is received by thepower circuits 72. - The
processing unit 78 can also include safety control logic. The safety control logic detects when the temperature at atemperature sensor 20 has exceeded a safety threshold. Theprocessing unit 78 can then provide a temperature control signal which causes thepower circuits 72 to stop the delivery of energy from theenergy source 70 to theultrasound elements 40. - Since, the
ultrasound elements 40 may be mobile relative to thetemperature sensors 20, it can be unclear which ultrasound transducer should have a power level adjustment. As a result, the power level may be identically adjusted at eachultrasound element 40. Further, the power supplied to each of theultrasound elements 40 may be adjusted in response to thetemperature sensor 20 which indicates the highest temperature. Making power adjustments in response to the temperature of thetemperature sensor 20 indicating the highest temperature can prevent overheating of the treatment site. - The
processing unit 78 also receives a power signal from apower calculation device 74. The power signal can be used to determine the power being received by eachultrasound element 40. The determined power can then be displayed to the user on the user interface anddisplay 80. - The feedback control system68 can maintain the tissue adjacent to the
ultrasound elements 40 at a desired temperature for a selected period of time. As described above, theultrasound elements 40 can be electrically connected so eachultrasound element 40 can generate an independent output. The output maintains a selected energy at eachultrasound element 40 for a selected length of time. - The
processing unit 78 can be a digital or analog controller, or a computer with software. When theprocessing unit 78 is a computer it can include a CPU coupled through a system bus. The user interface anddisplay 80 can be a mouse, keyboard, a disk drive, or other non-volatile memory systems, a display monitor, and other peripherals, as are known in the art. Also coupled to the bus is a program memory and a data memory. - In lieu of the series of power adjustments described above, a profile of the power delivered to each
ultrasound element 40 can be incorporated in theprocessing unit 78 and a preset amount of energy to be delivered may also be profiled. The power delivered to eachultrasound element 40 can the be adjusted according to the profiles. - FIGS.10A-10G illustrate a method for using the
system 10. In FIG. 10A, aguidewire 84 similar to a to a guidewire used in typical angioplasty procedures is directed throughvessels 86 toward atreatment site 88 which includes aclot 90. Theguidewire 84 is directed through theclot 90. Suitable vessels include, but are not limited to, cardiovascular vessels, the pancreas, sinuses, esophagus, rectum, gastrointestinal vessels and urological vessels. - In FIG. 10B, the
utility lumen 28 of thesheath 12 is slid over theguidewire 84 and thesheath 12 is advanced along theguidewire 84 using traditional over-the-guidewire techniques. Thesheath 12 is advanced until theenergy delivery section 18 of thesheath 12 is positioned at theclot 90. Radio opaque markers may be positioned at theenergy delivery section 18 of thesheath 12 to aid in the positioning of thesheath 12 within thetreatment site 88. - In FIG. 10C, the
guidewire 84 is withdrawn from theutility lumen 28 by pulling theguidewire 84 proximally while holding thesheath 12 stationary. In FIG. 10D, atemperature monitor 92 is coupled with the temperature sensor leads 24, a cooling fluid source 94 is coupled with the cooling fluid inlet and adrug solution source 96 is coupled with thedrug inlet port 32. Thedrug solution source 96 can be a syringe with a Luer fitting which is complementary with thedrug inlet port 32. Pressure can be applied to a plunger 98 on thedrug solution source 96 to drive the drug solution through thedrug delivery lumen 56. The drug solution is delivered from thedrug delivery lumen 56 through thedrug delivery ports 58 as illustrated by thearrows 100 in FIG. 10E. Suitable drug solutions include, but are not limited to, an aqueous solution containing Heparin, Uronkinase, Streptokinase, or tissue Plasminogen Activator (TPA). - In FIG. 10F, the
elongated body 34 is inserted into theutility lumen 28 until theultrasound element 40 is positioned within theenergy delivery section 18. To aid in placement of theultrasound element 40 within theenergy delivery section 18, radiopaque markers may be positioned on theelongated body 34 adjacent to each of theultrasound elements 40. Theultrasound elements 40 themselves can be radiopaque. Once theelongated body 34 is properly positioned, theultrasound element 40 is activated to deliver ultrasound energy through theenergy delivery section 18 to theclot 90. Suitable ultrasound energy is delivered with a frequency from 20 KHz to 2 MHz. While the ultrasound energy s being delivered, theultrasound element 40 can be moved within theenergy delivery section 18 as illustrated by the arrows 52. The movement of theultrasound element 40 within theenergy delivery section 18 can be caused by manipulating the body proximal section while holding the sheath proximal section stationary. A cooling fluid is flowed through the coolingfluid lumen 44 and out theocclusion device 22. - The cooling fluid can be delivered before, after, during or intermittently with the delivery of the ultrasound energy. Similarly, the drug solution can be delivered before, after, during or intermittently to the delivery of ultrasound energy. As a result, the acts illustrated in FIGS.10A-10F can be performed in different orders than are described above. The drug solution and energy are applied until the
clot 90 is partially or entirely dissolved as illustrated in FIG. 10G. Once theclot 90 has been dissolved to the desired degree, thesheath 12 andelongated body 34 are withdrawn from thetreatment site 88. - FIGS.11A-11B illustrate a method for using the
system 10 when the sheathdistal end 16 includes aballoon 59. Thesheath 12 is, advanced through avessel 86, as described above, until theballoon 59 is positioned adjacent aclot 90 as illustrated in FIG. 11A. Theballoon 59 is expanded until theballoon 59 contacts theclot 90 as illustrated in FIG. 11B. As described above, theballoon 59 can be expanded by delivering a drug solution through anexpansion port 60A or adrug delivery port 58 or by delivering an expansion media through anexpansion port 60A. Once theballoon 59 contacts theclot 90, the drug solution or components of the drug solution are driven across the membrane so the drug solution or the components of the drug solution contact theclot 90. Theelongated body 34 can be inserted into thesheath 12 before, after or concurrently with the expansion of theballoon 59 and/or the delivery of the drug solution. Similarly, theultrasound element 40 can be operated before, after, intermittently or concurrently with the expansion of theballoon 59 and/or the delivery of the drug solution. - The foregoing description of a preferred embodiment of the invention has been presented for purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise forms disclosed. Obviously, many modifications, combinations and variations will be apparent to practitioners skilled in this art.
Claims (59)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/369,271 US20040015122A1 (en) | 1998-06-29 | 2003-02-18 | Sheath for use with an ultrasound element |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/107,078 US6723063B1 (en) | 1998-06-29 | 1998-06-29 | Sheath for use with an ultrasound element |
US10/369,271 US20040015122A1 (en) | 1998-06-29 | 2003-02-18 | Sheath for use with an ultrasound element |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/107,078 Continuation US6723063B1 (en) | 1997-05-01 | 1998-06-29 | Sheath for use with an ultrasound element |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040015122A1 true US20040015122A1 (en) | 2004-01-22 |
Family
ID=22314719
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/107,078 Expired - Lifetime US6723063B1 (en) | 1997-05-01 | 1998-06-29 | Sheath for use with an ultrasound element |
US10/369,270 Expired - Fee Related US7413556B2 (en) | 1998-06-29 | 2003-02-18 | Sheath for use with an ultrasound element |
US10/369,271 Abandoned US20040015122A1 (en) | 1998-06-29 | 2003-02-18 | Sheath for use with an ultrasound element |
US11/418,491 Abandoned US20070112268A1 (en) | 1998-06-29 | 2006-05-03 | Sheath for use with an ultrasound element |
US13/332,226 Expired - Fee Related US8764700B2 (en) | 1998-06-29 | 2011-12-20 | Sheath for use with an ultrasound element |
US14/289,528 Abandoned US20140343483A1 (en) | 1998-06-29 | 2014-05-28 | Sheath for use with an ultrasound element |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/107,078 Expired - Lifetime US6723063B1 (en) | 1997-05-01 | 1998-06-29 | Sheath for use with an ultrasound element |
US10/369,270 Expired - Fee Related US7413556B2 (en) | 1998-06-29 | 2003-02-18 | Sheath for use with an ultrasound element |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/418,491 Abandoned US20070112268A1 (en) | 1998-06-29 | 2006-05-03 | Sheath for use with an ultrasound element |
US13/332,226 Expired - Fee Related US8764700B2 (en) | 1998-06-29 | 2011-12-20 | Sheath for use with an ultrasound element |
US14/289,528 Abandoned US20140343483A1 (en) | 1998-06-29 | 2014-05-28 | Sheath for use with an ultrasound element |
Country Status (5)
Country | Link |
---|---|
US (6) | US6723063B1 (en) |
EP (1) | EP1091699B1 (en) |
JP (1) | JP4890674B2 (en) |
DE (1) | DE69925122T2 (en) |
WO (1) | WO2000000095A1 (en) |
Cited By (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040199228A1 (en) * | 2003-01-03 | 2004-10-07 | Wilson Richard R. | Ultrasonic catheter with axial energy field |
US20160001038A1 (en) * | 2014-07-01 | 2016-01-07 | Auris Surgical Robotics, Inc. | Tool and method for using surgical endoscope with spiral lumens |
US9415242B2 (en) | 2001-12-03 | 2016-08-16 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10080576B2 (en) | 2013-03-08 | 2018-09-25 | Auris Health, Inc. | Method, apparatus, and a system for facilitating bending of an instrument in a surgical or medical robotic environment |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10130427B2 (en) | 2010-09-17 | 2018-11-20 | Auris Health, Inc. | Systems and methods for positioning an elongate member inside a body |
US10149720B2 (en) | 2013-03-08 | 2018-12-11 | Auris Health, Inc. | Method, apparatus, and a system for facilitating bending of an instrument in a surgical or medical robotic environment |
US10363103B2 (en) | 2009-04-29 | 2019-07-30 | Auris Health, Inc. | Flexible and steerable elongate instruments with shape control and support elements |
US10376672B2 (en) | 2013-03-15 | 2019-08-13 | Auris Health, Inc. | Catheter insertion system and method of fabrication |
US10398518B2 (en) | 2014-07-01 | 2019-09-03 | Auris Health, Inc. | Articulating flexible endoscopic tool with roll capabilities |
US10405939B2 (en) | 2013-10-24 | 2019-09-10 | Auris Health, Inc. | Endoscopic device with helical lumen design |
US10463439B2 (en) | 2016-08-26 | 2019-11-05 | Auris Health, Inc. | Steerable catheter with shaft load distributions |
US10493241B2 (en) | 2014-07-01 | 2019-12-03 | Auris Health, Inc. | Apparatuses and methods for monitoring tendons of steerable catheters |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US10667720B2 (en) | 2011-07-29 | 2020-06-02 | Auris Health, Inc. | Apparatus and methods for fiber integration and registration |
US10716461B2 (en) | 2017-05-17 | 2020-07-21 | Auris Health, Inc. | Exchangeable working channel |
US10898276B2 (en) | 2018-08-07 | 2021-01-26 | Auris Health, Inc. | Combining strain-based shape sensing with catheter control |
US11109920B2 (en) | 2018-03-28 | 2021-09-07 | Auris Health, Inc. | Medical instruments with variable bending stiffness profiles |
US11179212B2 (en) | 2018-09-26 | 2021-11-23 | Auris Health, Inc. | Articulating medical instruments |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
US11617627B2 (en) | 2019-03-29 | 2023-04-04 | Auris Health, Inc. | Systems and methods for optical strain sensing in medical instruments |
US11672553B2 (en) | 2007-06-22 | 2023-06-13 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US11717147B2 (en) | 2019-08-15 | 2023-08-08 | Auris Health, Inc. | Medical device having multiple bending sections |
US11819636B2 (en) | 2015-03-30 | 2023-11-21 | Auris Health, Inc. | Endoscope pull wire electrical circuit |
US11925367B2 (en) | 2007-01-08 | 2024-03-12 | Ekos Corporation | Power parameters for ultrasonic catheter |
US11950872B2 (en) | 2019-12-31 | 2024-04-09 | Auris Health, Inc. | Dynamic pulley system |
US11986257B2 (en) | 2018-12-28 | 2024-05-21 | Auris Health, Inc. | Medical instrument with articulable segment |
Families Citing this family (172)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69215722T3 (en) * | 1991-03-22 | 2001-03-08 | Katsuro Tachibana | Amplifiers for ultrasound therapy of diseases and liquid pharmaceutical compositions containing them |
US6210356B1 (en) * | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6302875B1 (en) | 1996-10-11 | 2001-10-16 | Transvascular, Inc. | Catheters and related devices for forming passageways between blood vessels or other anatomical structures |
US6582392B1 (en) * | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6723063B1 (en) | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6398772B1 (en) * | 1999-03-26 | 2002-06-04 | Coraje, Inc. | Method and apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion |
EP1206771A1 (en) | 1999-08-16 | 2002-05-22 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US8241274B2 (en) | 2000-01-19 | 2012-08-14 | Medtronic, Inc. | Method for guiding a medical device |
US6638246B1 (en) | 2000-11-28 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device for delivery of a biologically active material to a lumen |
US6623444B2 (en) * | 2001-03-21 | 2003-09-23 | Advanced Medical Applications, Inc. | Ultrasonic catheter drug delivery method and device |
US8123789B2 (en) * | 2002-04-29 | 2012-02-28 | Rohit Khanna | Central nervous system cooling catheter |
US20040019318A1 (en) * | 2001-11-07 | 2004-01-29 | Wilson Richard R. | Ultrasound assembly for use with a catheter |
US7018354B2 (en) * | 2001-11-08 | 2006-03-28 | El Hassane Tazi | Liposuction devices and methods and surrounding aspiration systems and methods |
EP1450900B1 (en) * | 2001-12-03 | 2006-07-26 | Ekos Corporation | Small vessel ultrasound catheter |
US6979293B2 (en) | 2001-12-14 | 2005-12-27 | Ekos Corporation | Blood flow reestablishment determination |
US6958040B2 (en) | 2001-12-28 | 2005-10-25 | Ekos Corporation | Multi-resonant ultrasonic catheter |
US20040068189A1 (en) | 2002-02-28 | 2004-04-08 | Wilson Richard R. | Ultrasound catheter with embedded conductors |
US8226629B1 (en) | 2002-04-01 | 2012-07-24 | Ekos Corporation | Ultrasonic catheter power control |
US7756583B2 (en) | 2002-04-08 | 2010-07-13 | Ardian, Inc. | Methods and apparatus for intravascularly-induced neuromodulation |
US20080213331A1 (en) | 2002-04-08 | 2008-09-04 | Ardian, Inc. | Methods and devices for renal nerve blocking |
US20070135875A1 (en) | 2002-04-08 | 2007-06-14 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US8347891B2 (en) | 2002-04-08 | 2013-01-08 | Medtronic Ardian Luxembourg S.A.R.L. | Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen |
US8150519B2 (en) | 2002-04-08 | 2012-04-03 | Ardian, Inc. | Methods and apparatus for bilateral renal neuromodulation |
US20070129761A1 (en) | 2002-04-08 | 2007-06-07 | Ardian, Inc. | Methods for treating heart arrhythmia |
US9636174B2 (en) | 2002-04-08 | 2017-05-02 | Medtronic Ardian Luxembourg S.A.R.L. | Methods for therapeutic renal neuromodulation |
US7617005B2 (en) | 2002-04-08 | 2009-11-10 | Ardian, Inc. | Methods and apparatus for thermally-induced renal neuromodulation |
US9955994B2 (en) | 2002-08-02 | 2018-05-01 | Flowcardia, Inc. | Ultrasound catheter having protective feature against breakage |
US7613503B2 (en) * | 2002-08-09 | 2009-11-03 | Boston Scientific Scimed, Inc. | Device with infusion holes for imaging inside a blood vessel |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US6942677B2 (en) | 2003-02-26 | 2005-09-13 | Flowcardia, Inc. | Ultrasound catheter apparatus |
US6921371B2 (en) * | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
EP1619995A2 (en) * | 2003-04-22 | 2006-02-01 | Ekos Corporation | Ultrasound enhanced central venous catheter |
DE202004021946U1 (en) | 2003-09-12 | 2013-05-29 | Vessix Vascular, Inc. | Selectable eccentric remodeling and / or ablation of atherosclerotic material |
US7758510B2 (en) | 2003-09-19 | 2010-07-20 | Flowcardia, Inc. | Connector for securing ultrasound catheter to transducer |
US20060058708A1 (en) * | 2003-12-24 | 2006-03-16 | Gill Heart | Method and apparatus for ultrasonically increasing the transportation of therapeutic substances through tissue |
US20050209578A1 (en) * | 2004-01-29 | 2005-09-22 | Christian Evans Edward A | Ultrasonic catheter with segmented fluid delivery |
US7201737B2 (en) * | 2004-01-29 | 2007-04-10 | Ekos Corporation | Treatment of vascular occlusions using elevated temperatures |
CA2553165A1 (en) * | 2004-01-29 | 2005-08-11 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
WO2005072391A2 (en) * | 2004-01-29 | 2005-08-11 | Ekos Corporation | Small vessel ultrasound catheter |
US7341569B2 (en) * | 2004-01-30 | 2008-03-11 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
WO2005094283A2 (en) * | 2004-03-25 | 2005-10-13 | Hauser David L | Vascular filter device |
US8920414B2 (en) | 2004-09-10 | 2014-12-30 | Vessix Vascular, Inc. | Tuned RF energy and electrical tissue characterization for selective treatment of target tissues |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US20060184070A1 (en) * | 2004-11-12 | 2006-08-17 | Hansmann Douglas R | External ultrasonic therapy |
CN101076290B (en) | 2004-12-09 | 2011-11-23 | 铸造品股份有限公司 | Aortic valve repair |
US20060173387A1 (en) * | 2004-12-10 | 2006-08-03 | Douglas Hansmann | Externally enhanced ultrasonic therapy |
CA2604380A1 (en) * | 2005-04-12 | 2006-10-19 | Ekos Corporation | Ultrasound catheter with cavitation promoting surface |
US7918870B2 (en) | 2005-09-12 | 2011-04-05 | Bridgepoint Medical, Inc. | Endovascular devices and methods |
US20080177220A1 (en) * | 2006-01-06 | 2008-07-24 | The Curators Of The University Of Missouri | Ultrasound-Mediated Transcleral Drug Delivery |
EP2015846A2 (en) | 2006-04-24 | 2009-01-21 | Ekos Corporation | Ultrasound therapy system |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
US20080039746A1 (en) | 2006-05-25 | 2008-02-14 | Medtronic, Inc. | Methods of using high intensity focused ultrasound to form an ablated tissue area containing a plurality of lesions |
AU2007310986B2 (en) | 2006-10-18 | 2013-07-04 | Boston Scientific Scimed, Inc. | Inducing desirable temperature effects on body tissue |
WO2008049087A2 (en) | 2006-10-18 | 2008-04-24 | Minnow Medical, Inc. | System for inducing desirable temperature effects on body tissue |
US8192363B2 (en) * | 2006-10-27 | 2012-06-05 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US8246643B2 (en) | 2006-11-07 | 2012-08-21 | Flowcardia, Inc. | Ultrasound catheter having improved distal end |
EP2111261B1 (en) * | 2007-01-08 | 2015-04-15 | Ekos Corporation | Power parameters for ultrasonic catheter |
LT2166855T (en) * | 2007-06-07 | 2018-06-25 | Bayer Animal Health Gmbh | Control of ectoparasites |
US8906700B2 (en) | 2007-11-06 | 2014-12-09 | Ambergen, Inc. | Methods and compositions for phototransfer |
EP2231024A4 (en) * | 2007-12-14 | 2015-03-18 | Ekos Corp | Ultrasound pulse shaping |
US8403911B2 (en) * | 2008-04-22 | 2013-03-26 | Becton, Dickinson And Company | Systems and methods for improving catheter hole array efficiency |
US8496629B2 (en) | 2008-04-22 | 2013-07-30 | Becton, Dickinson And Company | Catheter hole having a flow breaking feature |
US9399112B2 (en) | 2008-04-22 | 2016-07-26 | Becton, Dickinson And Company | Catheter hole having an inclined trailing edge |
US9364634B2 (en) | 2008-04-22 | 2016-06-14 | Becton, Dickinson And Company | Systems and methods for improving catheter hole array efficiency |
EP2764818B1 (en) * | 2008-10-20 | 2020-08-19 | Smart Medical Systems Ltd. | Assemblies for use with endoscopes and applications thereof |
JP5307900B2 (en) | 2008-11-17 | 2013-10-02 | べシックス・バスキュラー・インコーポレイテッド | Selective energy storage without knowledge of organizational topography |
WO2011003031A1 (en) * | 2009-07-03 | 2011-01-06 | Ekos Corporation | Power parameters for ultrasonic catheter |
WO2011030470A1 (en) * | 2009-09-11 | 2011-03-17 | Olympus Medical Systems Corp. | Treatment apparatus and operation system |
WO2011033682A1 (en) * | 2009-09-18 | 2011-03-24 | Olympus Medical Systems Corp. | Treatment apparatus and operation system |
US20110105960A1 (en) * | 2009-10-06 | 2011-05-05 | Wallace Michael P | Ultrasound-enhanced Stenosis therapy |
US9375223B2 (en) | 2009-10-06 | 2016-06-28 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110082396A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US11039845B2 (en) | 2009-10-06 | 2021-06-22 | Cardioprolific Inc. | Methods and devices for endovascular therapy |
US20110082534A1 (en) * | 2009-10-06 | 2011-04-07 | Wallace Michael P | Ultrasound-enhanced stenosis therapy |
US8740835B2 (en) * | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
JP2013523318A (en) | 2010-04-09 | 2013-06-17 | べシックス・バスキュラー・インコーポレイテッド | Power generation and control equipment for tissue treatment |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US10888657B2 (en) | 2010-08-27 | 2021-01-12 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US9180274B2 (en) | 2010-09-09 | 2015-11-10 | W. L. G ore & Associates, Inc | Indwelling luminal devices |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
JP5604409B2 (en) * | 2011-01-19 | 2014-10-08 | 富士フイルム株式会社 | Endoscope |
KR20130131471A (en) | 2011-04-08 | 2013-12-03 | 코비디엔 엘피 | Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery |
TW201242570A (en) | 2011-04-25 | 2012-11-01 | Medtronic Ardian Luxembourg | Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
CN103813829B (en) | 2011-07-22 | 2016-05-18 | 波士顿科学西美德公司 | There is the neuromodulation system of the neuromodulation element that can be positioned in spiral guiding piece |
US9186210B2 (en) | 2011-10-10 | 2015-11-17 | Boston Scientific Scimed, Inc. | Medical devices including ablation electrodes |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
EP2765940B1 (en) | 2011-10-11 | 2015-08-26 | Boston Scientific Scimed, Inc. | Off-wall electrode device for nerve modulation |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
EP2768568B1 (en) | 2011-10-18 | 2020-05-06 | Boston Scientific Scimed, Inc. | Integrated crossing balloon catheter |
WO2013058962A1 (en) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CN108095821B (en) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | Orifice renal nerve ablation |
US9119600B2 (en) | 2011-11-15 | 2015-09-01 | Boston Scientific Scimed, Inc. | Device and methods for renal nerve modulation monitoring |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
US9174050B2 (en) | 2011-12-23 | 2015-11-03 | Vessix Vascular, Inc. | Methods and apparatuses for remodeling tissue of or adjacent to a body passage |
CN104135958B (en) | 2011-12-28 | 2017-05-03 | 波士顿科学西美德公司 | By the apparatus and method that have the new ablation catheter modulation nerve of polymer ablation |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9603615B2 (en) | 2012-01-18 | 2017-03-28 | C.R. Bard, Inc. | Vascular re-entry device |
JP2015128457A (en) * | 2012-04-27 | 2015-07-16 | テルモ株式会社 | embolus discharge catheter |
WO2013169927A1 (en) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices |
JP2014000311A (en) * | 2012-06-20 | 2014-01-09 | Olympus Corp | Ultrasonic treatment instrument |
WO2014022716A2 (en) | 2012-08-02 | 2014-02-06 | Flowcardia, Inc. | Ultrasound catheter system |
US10321946B2 (en) | 2012-08-24 | 2019-06-18 | Boston Scientific Scimed, Inc. | Renal nerve modulation devices with weeping RF ablation balloons |
EP2895095A2 (en) | 2012-09-17 | 2015-07-22 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
WO2014047411A1 (en) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
US10549127B2 (en) | 2012-09-21 | 2020-02-04 | Boston Scientific Scimed, Inc. | Self-cooling ultrasound ablation catheter |
CN104869930B (en) | 2012-10-10 | 2020-12-25 | 波士顿科学国际有限公司 | Renal neuromodulation apparatus and methods |
WO2014163987A1 (en) | 2013-03-11 | 2014-10-09 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
WO2014143571A1 (en) | 2013-03-11 | 2014-09-18 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
SG11201506154RA (en) | 2013-03-14 | 2015-09-29 | Ekos Corp | Method and apparatus for drug delivery to a target site |
JP6220044B2 (en) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Medical device for renal nerve ablation |
CN105228546B (en) | 2013-03-15 | 2017-11-14 | 波士顿科学国际有限公司 | Utilize the impedance-compensated medicine equipment and method that are used to treat hypertension |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
JP2016523147A (en) | 2013-06-21 | 2016-08-08 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Renal denervation balloon catheter with a riding-type electrode support |
WO2014205399A1 (en) | 2013-06-21 | 2014-12-24 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
CN105358084B (en) | 2013-07-01 | 2018-11-09 | 波士顿科学国际有限公司 | Medical instrument for renal nerve ablation |
CN105377169B (en) | 2013-07-11 | 2019-04-19 | 波士顿科学国际有限公司 | Device and method for neuromodulation |
WO2015006573A1 (en) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Medical device with stretchable electrode assemblies |
US9925001B2 (en) | 2013-07-19 | 2018-03-27 | Boston Scientific Scimed, Inc. | Spiral bipolar electrode renal denervation balloon |
WO2015013205A1 (en) | 2013-07-22 | 2015-01-29 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
US10695124B2 (en) | 2013-07-22 | 2020-06-30 | Boston Scientific Scimed, Inc. | Renal nerve ablation catheter having twist balloon |
JP6159888B2 (en) | 2013-08-22 | 2017-07-05 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Flexible circuit with improved adhesion to renal neuromodulation balloon |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
WO2015038947A1 (en) | 2013-09-13 | 2015-03-19 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
CN105592778B (en) | 2013-10-14 | 2019-07-23 | 波士顿科学医学有限公司 | High-resolution cardiac mapping electrod-array conduit |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
US9962223B2 (en) | 2013-10-15 | 2018-05-08 | Boston Scientific Scimed, Inc. | Medical device balloon |
WO2015057961A1 (en) | 2013-10-18 | 2015-04-23 | Boston Scientific Scimed, Inc. | Balloon catheters with flexible conducting wires and related methods of use and manufacture |
CN105658163B (en) | 2013-10-25 | 2020-08-18 | 波士顿科学国际有限公司 | Embedded thermocouple in denervation flexible circuit |
WO2015103617A1 (en) | 2014-01-06 | 2015-07-09 | Boston Scientific Scimed, Inc. | Tear resistant flex circuit assembly |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
JP6325121B2 (en) | 2014-02-04 | 2018-05-16 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Alternative placement of temperature sensors on bipolar electrodes |
US10709490B2 (en) | 2014-05-07 | 2020-07-14 | Medtronic Ardian Luxembourg S.A.R.L. | Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods |
US10226595B2 (en) * | 2014-06-16 | 2019-03-12 | Edwards Lifesciences Corporation | Spring cannulae |
JP2015042272A (en) * | 2014-10-03 | 2015-03-05 | マイクロベンション インコーポレイテッド | Embolectomy catheter and handling method |
ES2940906T3 (en) * | 2015-04-08 | 2023-05-12 | Massachusetts Inst Technology | Device for administering a substance |
US10470790B2 (en) * | 2015-12-16 | 2019-11-12 | Ethicon Llc | Surgical instrument with selector |
US11432794B2 (en) * | 2016-09-28 | 2022-09-06 | Koninklijke Philips N.V. | Blood flow determination apparatus |
US10610668B2 (en) | 2016-10-05 | 2020-04-07 | Becton, Dickinson And Company | Catheter with an asymmetric tip |
US20180140321A1 (en) | 2016-11-23 | 2018-05-24 | C. R. Bard, Inc. | Catheter With Retractable Sheath And Methods Thereof |
US11596726B2 (en) | 2016-12-17 | 2023-03-07 | C.R. Bard, Inc. | Ultrasound devices for removing clots from catheters and related methods |
US10758256B2 (en) | 2016-12-22 | 2020-09-01 | C. R. Bard, Inc. | Ultrasonic endovascular catheter |
US10582983B2 (en) | 2017-02-06 | 2020-03-10 | C. R. Bard, Inc. | Ultrasonic endovascular catheter with a controllable sheath |
US11116561B2 (en) | 2018-01-24 | 2021-09-14 | Medtronic Ardian Luxembourg S.A.R.L. | Devices, agents, and associated methods for selective modulation of renal nerves |
WO2020030662A1 (en) * | 2018-08-08 | 2020-02-13 | Koninklijke Philips N.V. | Interventional device with an ultrasound transducer |
US11793392B2 (en) * | 2019-04-17 | 2023-10-24 | Neptune Medical Inc. | External working channels |
USD974558S1 (en) | 2020-12-18 | 2023-01-03 | Stryker European Operations Limited | Ultrasonic knife |
US20230346205A1 (en) | 2022-04-27 | 2023-11-02 | Neptune Medical Inc. | Multi-lumen port adapter manifold devices and methods of use |
Citations (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3433226A (en) * | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
US4040414A (en) * | 1976-05-12 | 1977-08-09 | Xygiene, Inc. | Ultrasonic personal care instrument and method |
US4319580A (en) * | 1979-08-28 | 1982-03-16 | The Board Of Regents Of The University Of Washington | Method for detecting air emboli in the blood in an intracorporeal blood vessel |
US4531943A (en) * | 1983-08-08 | 1985-07-30 | Angiomedics Corporation | Catheter with soft deformable tip |
US4750902A (en) * | 1985-08-28 | 1988-06-14 | Sonomed Technology, Inc. | Endoscopic ultrasonic aspirators |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
US4821740A (en) * | 1986-11-26 | 1989-04-18 | Shunro Tachibana | Endermic application kits for external medicines |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US4924863A (en) * | 1988-05-04 | 1990-05-15 | Mmtc, Inc. | Angioplastic method for removing plaque from a vas |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
US4948587A (en) * | 1986-07-08 | 1990-08-14 | Massachusetts Institute Of Technology | Ultrasound enhancement of transbuccal drug delivery |
US5021044A (en) * | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
US5108369A (en) * | 1990-03-15 | 1992-04-28 | Diagnostic Devices Group, Limited | Dual-diameter multifunction catheter |
US5197946A (en) * | 1990-06-27 | 1993-03-30 | Shunro Tachibana | Injection instrument with ultrasonic oscillating element |
US5226421A (en) * | 1992-03-06 | 1993-07-13 | Cardiometrics, Inc. | Doppler elongate flexible member having an inflatable balloon mounted thereon |
US5282785A (en) * | 1990-06-15 | 1994-02-01 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5295484A (en) * | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5307816A (en) * | 1991-08-21 | 1994-05-03 | Kabushiki Kaisha Toshiba | Thrombus resolving treatment apparatus |
US5313949A (en) * | 1986-02-28 | 1994-05-24 | Cardiovascular Imaging Systems Incorporated | Method and apparatus for intravascular two-dimensional ultrasonography |
US5318014A (en) * | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
US5323769A (en) * | 1990-02-23 | 1994-06-28 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
US5327891A (en) * | 1992-07-30 | 1994-07-12 | Rammler David H | Catheter track and catheter for diagnosis and treatment |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5344395A (en) * | 1989-11-13 | 1994-09-06 | Scimed Life Systems, Inc. | Apparatus for intravascular cavitation or delivery of low frequency mechanical energy |
US5344435A (en) * | 1988-07-28 | 1994-09-06 | Bsd Medical Corporation | Urethral inserted applicator prostate hyperthermia |
US5345940A (en) * | 1991-11-08 | 1994-09-13 | Mayo Foundation For Medical Education And Research | Transvascular ultrasound hemodynamic and interventional catheter and method |
US5380273A (en) * | 1992-05-19 | 1995-01-10 | Dubrul; Will R. | Vibrating catheter |
US5385148A (en) * | 1993-07-30 | 1995-01-31 | The Regents Of The University Of California | Cardiac imaging and ablation catheter |
US5390678A (en) * | 1993-10-12 | 1995-02-21 | Baxter International Inc. | Method and device for measuring ultrasonic activity in an ultrasound delivery system |
US5397293A (en) * | 1992-11-25 | 1995-03-14 | Misonix, Inc. | Ultrasonic device with sheath and transverse motion damping |
US5421338A (en) * | 1988-03-21 | 1995-06-06 | Boston Scientific Corporation | Acoustic imaging catheter and the like |
US5423797A (en) * | 1994-04-25 | 1995-06-13 | Medelex, Inc. | Acoustic catheter with rotary drive |
US5431663A (en) * | 1990-12-10 | 1995-07-11 | Coraje, Inc. | Miniature ultrasonic transducer for removal of intravascular plaque and clots |
US5445155A (en) * | 1991-03-13 | 1995-08-29 | Scimed Life Systems Incorporated | Intravascular imaging apparatus and methods for use and manufacture |
US5498238A (en) * | 1990-06-15 | 1996-03-12 | Cortrak Medical, Inc. | Simultaneous angioplasty and phoretic drug delivery |
US5509896A (en) * | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
US5514092A (en) * | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
US5520189A (en) * | 1990-07-13 | 1996-05-28 | Coraje, Inc. | Intravascular ultrasound imaging guidewire |
US5523058A (en) * | 1992-09-16 | 1996-06-04 | Hitachi, Ltd. | Ultrasonic irradiation apparatus and processing apparatus based thereon |
US5533986A (en) * | 1994-02-18 | 1996-07-09 | Merit Medical Systems, Inc. | Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament |
US5603694A (en) * | 1995-10-17 | 1997-02-18 | Brown; Joe E. | Infusion coil apparatus and method for delivering fluid-based agents intravascularly |
US5603327A (en) * | 1993-02-01 | 1997-02-18 | Endosonics Corporation | Ultrasound catheter probe |
US5606974A (en) * | 1995-05-02 | 1997-03-04 | Heart Rhythm Technologies, Inc. | Catheter having ultrasonic device |
US5617851A (en) * | 1992-10-14 | 1997-04-08 | Endodermic Medical Technologies Company | Ultrasonic transdermal system for withdrawing fluid from an organism and determining the concentration of a substance in the fluid |
US5618275A (en) * | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
US5620479A (en) * | 1992-11-13 | 1997-04-15 | The Regents Of The University Of California | Method and apparatus for thermal therapy of tumors |
US5628728A (en) * | 1995-05-31 | 1997-05-13 | Ekos Corporation | Medicine applying tool |
US5630837A (en) * | 1993-07-01 | 1997-05-20 | Boston Scientific Corporation | Acoustic ablation |
US5656016A (en) * | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
US5660182A (en) * | 1993-09-20 | 1997-08-26 | Colin Corporation | Inflatable cuff used for blood pressure measurement and automatic blood pressure measuring apparatus including inflatable cuff |
US5713848A (en) * | 1993-05-19 | 1998-02-03 | Dubrul; Will R. | Vibrating catheter |
US5713831A (en) * | 1992-02-17 | 1998-02-03 | Olsson; Sten Bertil | Method and apparatus for arterial reperfusion through noninvasive ultrasonic action |
US5725494A (en) * | 1995-11-30 | 1998-03-10 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced intraluminal therapy |
US5735811A (en) * | 1995-11-30 | 1998-04-07 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced fluid delivery |
US5772632A (en) * | 1994-04-13 | 1998-06-30 | Schneider (Usa) Inc. | Dilation-drug delivery catheter |
US5779673A (en) * | 1995-06-26 | 1998-07-14 | Focal, Inc. | Devices and methods for application of intraluminal photopolymerized gels |
US5876345A (en) * | 1997-02-27 | 1999-03-02 | Acuson Corporation | Ultrasonic catheter, system and method for two dimensional imaging or three-dimensional reconstruction |
US5916192A (en) * | 1991-01-11 | 1999-06-29 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty-atherectomy catheter and method of use |
US5931805A (en) * | 1997-06-02 | 1999-08-03 | Pharmasonics, Inc. | Catheters comprising bending transducers and methods for their use |
US5941868A (en) * | 1995-12-22 | 1999-08-24 | Localmed, Inc. | Localized intravascular delivery of growth factors for promotion of angiogenesis |
US6024718A (en) * | 1996-09-04 | 2000-02-15 | The Regents Of The University Of California | Intraluminal directed ultrasound delivery device |
US6053868A (en) * | 1997-04-24 | 2000-04-25 | Sulzer Osypka Gmbh | Apparatus for a cardiological therapy |
US6059731A (en) * | 1998-08-19 | 2000-05-09 | Mayo Foundation For Medical Education And Research | Simultaneous side-and-end viewing underfluid catheter |
US6063069A (en) * | 1997-05-19 | 2000-05-16 | Micro Therapeutics Inc. | Method and apparatus for power lysis of a thrombus |
US6078830A (en) * | 1997-10-01 | 2000-06-20 | Ep Technologies, Inc. | Molded catheter distal end assembly and process for the manufacture thereof |
US6096000A (en) * | 1997-06-23 | 2000-08-01 | Ekos Corporation | Apparatus for transport of fluids across, into or from biological tissues |
US6110314A (en) * | 1994-03-11 | 2000-08-29 | Intravascular Research Limited | Ultrasonic transducer array and method of manufacturing the same |
US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US6206831B1 (en) * | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
US6210356B1 (en) * | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6228046B1 (en) * | 1997-06-02 | 2001-05-08 | Pharmasonics, Inc. | Catheters comprising a plurality of oscillators and methods for their use |
US6277077B1 (en) * | 1998-11-16 | 2001-08-21 | Cardiac Pathways Corporation | Catheter including ultrasound transducer with emissions attenuation |
US20020032394A1 (en) * | 2000-03-08 | 2002-03-14 | Axel Brisken | Methods, systems, and kits for plaque stabilization |
US6361500B1 (en) * | 2000-02-07 | 2002-03-26 | Scimed Life Systems, Inc. | Three transducer catheter |
US6372498B2 (en) * | 1997-12-31 | 2002-04-16 | Pharmasonics, Inc. | Methods, systems, and kits for intravascular nucleic acid delivery |
US6379320B1 (en) * | 1997-06-11 | 2002-04-30 | Institut National De La Santa Et De La Recherche Medicale I.N.S.E.R.M. | Ultrasound applicator for heating an ultrasound absorbent medium |
US6437487B1 (en) * | 2001-02-28 | 2002-08-20 | Acuson Corporation | Transducer array using multi-layered elements and a method of manufacture thereof |
US6524300B2 (en) * | 2000-01-03 | 2003-02-25 | Angiodynamics, Inc. | Infusion catheter with non-uniform drug delivery density |
US6542767B1 (en) * | 1999-11-09 | 2003-04-01 | Biotex, Inc. | Method and system for controlling heat delivery to a target |
US6561998B1 (en) * | 1998-04-07 | 2003-05-13 | Transvascular, Inc. | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
US6579279B1 (en) * | 1999-09-24 | 2003-06-17 | Omnisonics Medical Technologies, Inc. | Steerable catheter device |
US6585763B1 (en) * | 1997-10-14 | 2003-07-01 | Vascusense, Inc. | Implantable therapeutic device and method |
US6589182B1 (en) * | 2001-02-12 | 2003-07-08 | Acuson Corporation | Medical diagnostic ultrasound catheter with first and second tip portions |
US6599288B2 (en) * | 2000-05-16 | 2003-07-29 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US20040019318A1 (en) * | 2001-11-07 | 2004-01-29 | Wilson Richard R. | Ultrasound assembly for use with a catheter |
US20040024393A1 (en) * | 2002-08-02 | 2004-02-05 | Henry Nita | Therapeutic ultrasound system |
US20040024347A1 (en) * | 2001-12-03 | 2004-02-05 | Wilson Richard R. | Catheter with multiple ultrasound radiating members |
US20040049148A1 (en) * | 2001-12-03 | 2004-03-11 | Oscar Rodriguez | Small vessel ultrasound catheter |
US6711953B2 (en) * | 2000-08-25 | 2004-03-30 | Furuno Electric Company, Ltd. | Method of and apparatus for controlling beams produced by a cylindrical transducer |
US6740040B1 (en) * | 2001-01-30 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Ultrasound energy driven intraventricular catheter to treat ischemia |
US6758857B2 (en) * | 2000-11-13 | 2004-07-06 | Acmi Corporation | Treatment catheters with thermally insulated regions |
US20050004373A1 (en) * | 2003-07-04 | 2005-01-06 | Kumar Bobba Venkata Siva | Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman |
US7089063B2 (en) * | 2000-05-16 | 2006-08-08 | Atrionix, Inc. | Deflectable tip catheter with guidewire tracking mechanism |
Family Cites Families (287)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3430625A (en) | 1965-10-23 | 1969-03-04 | Mennen Greatbatch Electronics | Ultrasonic flowmeter for measuring blood flow |
US3565062A (en) | 1968-06-13 | 1971-02-23 | Ultrasonic Systems | Ultrasonic method and apparatus for removing cholesterol and other deposits from blood vessels and the like |
FR2173115B1 (en) | 1972-02-22 | 1977-09-02 | Univ Erasmus | |
US3941122A (en) | 1974-04-08 | 1976-03-02 | Bolt Beranek And Newman, Inc. | High frequency ultrasonic process and apparatus for selectively dissolving and removing unwanted solid and semi-solid materials and the like |
US4309989A (en) | 1976-02-09 | 1982-01-12 | The Curators Of The University Of Missouri | Topical application of medication by ultrasound with coupling agent |
US4192294A (en) | 1977-10-11 | 1980-03-11 | Gekhman Boris S | Method of removing concretions from the ureter |
US4354502A (en) | 1979-08-28 | 1982-10-19 | The Board Of Regents Of The University Of Washington | Intravascular catheter including untrasonic transducer for use in detection and aspiration of air emboli |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4549533A (en) | 1984-01-30 | 1985-10-29 | University Of Illinois | Apparatus and method for generating and directing ultrasound |
US4587975A (en) | 1984-07-02 | 1986-05-13 | Cardiac Pacemakers, Inc. | Dimension sensitive angioplasty catheter |
US4709698A (en) | 1986-05-14 | 1987-12-01 | Thomas J. Fogarty | Heatable dilation catheter |
US4754752A (en) | 1986-07-28 | 1988-07-05 | Robert Ginsburg | Vascular catheter |
GB2212267B (en) | 1987-11-11 | 1992-07-29 | Circulation Res Ltd | Methods and apparatus for the examination and treatment of internal organs |
US4870953A (en) | 1987-11-13 | 1989-10-03 | Donmicheal T Anthony | Intravascular ultrasonic catheter/probe and method for treating intravascular blockage |
JPH0629196B2 (en) | 1987-12-01 | 1994-04-20 | 甲子郎 梅村 | Physiological action enhancer for tumor treatment by ultrasound |
US5163421A (en) | 1988-01-22 | 1992-11-17 | Angiosonics, Inc. | In vivo ultrasonic system with angioplasty and ultrasonic contrast imaging |
US4921478A (en) | 1988-02-23 | 1990-05-01 | C. R. Bard, Inc. | Cerebral balloon angioplasty system |
US5588432A (en) | 1988-03-21 | 1996-12-31 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials, and ablating tissue |
US4951677A (en) | 1988-03-21 | 1990-08-28 | Prutech Research And Development Partnership Ii | Acoustic imaging catheter and the like |
US5178620A (en) | 1988-06-10 | 1993-01-12 | Advanced Angioplasty Products, Inc. | Thermal dilatation catheter and method |
US4960109A (en) | 1988-06-21 | 1990-10-02 | Massachusetts Institute Of Technology | Multi-purpose temperature sensing probe for hyperthermia therapy |
US5158071A (en) | 1988-07-01 | 1992-10-27 | Hitachi, Ltd. | Ultrasonic apparatus for therapeutical use |
US5542935A (en) | 1989-12-22 | 1996-08-06 | Imarx Pharmaceutical Corp. | Therapeutic delivery systems related applications |
US5088499A (en) | 1989-12-22 | 1992-02-18 | Unger Evan C | Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same |
US5149319A (en) | 1990-09-11 | 1992-09-22 | Unger Evan C | Methods for providing localized therapeutic heat to biological tissues and fluids |
US6088613A (en) | 1989-12-22 | 2000-07-11 | Imarx Pharmaceutical Corp. | Method of magnetic resonance focused surgical and therapeutic ultrasound |
US5069664A (en) | 1990-01-25 | 1991-12-03 | Inter Therapy, Inc. | Intravascular ultrasonic angioplasty probe |
DE4005743A1 (en) | 1990-02-23 | 1991-08-29 | Wolf Gmbh Richard | Lithotriptor to destroy gallstones intra-or trans-luminally - has shock-wave generator, lead contg. incompressible material, and opt balloon to press generator against gall bladder |
JP3015481B2 (en) | 1990-03-28 | 2000-03-06 | 株式会社東芝 | Ultrasonic probe system |
US5399158A (en) | 1990-05-31 | 1995-03-21 | The United States Of America As Represented By The Secretary Of The Army | Method of lysing thrombi |
JPH06503972A (en) | 1990-06-26 | 1994-05-12 | アドヴァンスド カーディオヴァスキュラーシステムズ インコーポレイテッド | Intravascular drug delivery method and catheter therefor |
US5279546A (en) | 1990-06-27 | 1994-01-18 | Lake Region Manufacturing Company, Inc. | Thrombolysis catheter system |
CA2022019C (en) | 1990-07-26 | 1992-12-29 | Michael Black | Catheter |
CA2048120A1 (en) | 1990-08-06 | 1992-02-07 | William J. Drasler | Thrombectomy method and device |
US5059851A (en) | 1990-09-06 | 1991-10-22 | Cardiometrics, Inc. | Miniature ultrasound high efficiency transducer assembly, guidewire using the same and method |
US5250034A (en) | 1990-09-17 | 1993-10-05 | E-Z-Em, Inc. | Pressure responsive valve catheter |
US5185071A (en) | 1990-10-30 | 1993-02-09 | Board Of Regents, The University Of Texas System | Programmable electrophoresis with integrated and multiplexed control |
US5368558A (en) | 1991-01-11 | 1994-11-29 | Baxter International Inc. | Ultrasonic ablation catheter device having endoscopic component and method of using same |
US5957882A (en) | 1991-01-11 | 1999-09-28 | Advanced Cardiovascular Systems, Inc. | Ultrasound devices for ablating and removing obstructive matter from anatomical passageways and blood vessels |
US5997497A (en) * | 1991-01-11 | 1999-12-07 | Advanced Cardiovascular Systems | Ultrasound catheter having integrated drug delivery system and methods of using same |
US5267954A (en) | 1991-01-11 | 1993-12-07 | Baxter International Inc. | Ultra-sound catheter for removing obstructions from tubular anatomical structures such as blood vessels |
US5447509A (en) | 1991-01-11 | 1995-09-05 | Baxter International Inc. | Ultrasound catheter system having modulated output with feedback control |
US5368557A (en) * | 1991-01-11 | 1994-11-29 | Baxter International Inc. | Ultrasonic ablation catheter device having multiple ultrasound transmission members |
US5542917A (en) | 1991-01-11 | 1996-08-06 | Baxter International, Inc. | Ultrasound delivery catheters incorporating improved distal tip construction |
US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
US6387052B1 (en) | 1991-01-29 | 2002-05-14 | Edwards Lifesciences Corporation | Thermodilution catheter having a safe, flexible heating element |
US5353798A (en) | 1991-03-13 | 1994-10-11 | Scimed Life Systems, Incorporated | Intravascular imaging apparatus and methods for use and manufacture |
DE69215722T3 (en) | 1991-03-22 | 2001-03-08 | Katsuro Tachibana | Amplifiers for ultrasound therapy of diseases and liquid pharmaceutical compositions containing them |
US5458568A (en) | 1991-05-24 | 1995-10-17 | Cortrak Medical, Inc. | Porous balloon for selective dilatation and drug delivery |
JP3181071B2 (en) | 1991-06-28 | 2001-07-03 | 俊郎 立花 | Blood processing equipment |
GB2258364A (en) | 1991-07-30 | 1993-02-03 | Intravascular Res Ltd | Ultrasonic tranducer |
US5219358A (en) | 1991-08-29 | 1993-06-15 | Ethicon, Inc. | Shape memory effect surgical needles |
WO1993008750A2 (en) | 1991-11-04 | 1993-05-13 | Baxter International Inc. | Ultrasonic ablation device adapted for guidewire passage |
EP0611310B1 (en) | 1991-11-08 | 1998-07-22 | Baxter International Inc. | Transport catheter and ultrasound probe for use with same |
DK171113B1 (en) | 1992-01-21 | 1996-06-17 | Baltic Technology Aps | Apparatus for removing biological tissue and with an ultrasonic vibrating probe, and method for making the apparatus |
GB2263974B (en) | 1992-01-30 | 1995-11-08 | Intravascular Res Ltd | Ultrasound imaging and catheters for use therein |
DE4207463C2 (en) | 1992-03-10 | 1996-03-28 | Siemens Ag | Arrangement for the therapy of tissue with ultrasound |
US5271406A (en) | 1992-05-22 | 1993-12-21 | Diagnostic Devices Group, Limited | Low-profile ultrasonic transducer incorporating static beam steering |
US5244395A (en) * | 1992-07-29 | 1993-09-14 | Motorola, Inc. | Circuit interconnect system |
US5261291A (en) | 1992-08-17 | 1993-11-16 | Schoch Paul T | Ergonomic apparatus for controlling a vehicle |
JPH0670987A (en) | 1992-08-28 | 1994-03-15 | Katsuro Tachibana | Medicine dosing and body liquid taking-out unit and device therefor |
US5362309A (en) | 1992-09-14 | 1994-11-08 | Coraje, Inc. | Apparatus and method for enhanced intravascular phonophoresis including dissolution of intravascular blockage and concomitant inhibition of restenosis |
JP2746021B2 (en) * | 1992-10-20 | 1998-04-28 | 富士写真光機株式会社 | Ultrasonic probe |
DE4235506A1 (en) | 1992-10-21 | 1994-04-28 | Bavaria Med Tech | Drug injection catheter |
US5807306A (en) | 1992-11-09 | 1998-09-15 | Cortrak Medical, Inc. | Polymer matrix drug delivery apparatus |
US6537306B1 (en) * | 1992-11-13 | 2003-03-25 | The Regents Of The University Of California | Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy |
US5733315A (en) | 1992-11-13 | 1998-03-31 | Burdette; Everette C. | Method of manufacture of a transurethral ultrasound applicator for prostate gland thermal therapy |
US5267985A (en) | 1993-02-11 | 1993-12-07 | Trancell, Inc. | Drug delivery by multiple frequency phonophoresis |
JP3578217B2 (en) | 1993-04-15 | 2004-10-20 | シーメンス アクチエンゲゼルシヤフト | Treatment device for treating heart disease and blood vessels near the heart |
US5462523A (en) | 1993-05-18 | 1995-10-31 | Target Therapeutics, Inc. | Drug delivery system |
DE69432148T2 (en) | 1993-07-01 | 2003-10-16 | Boston Scientific Ltd., St. Michael | CATHETER FOR IMAGE DISPLAY, DISPLAY OF ELECTRICAL SIGNALS AND ABLATION |
US5840031A (en) | 1993-07-01 | 1998-11-24 | Boston Scientific Corporation | Catheters for imaging, sensing electrical potentials and ablating tissue |
JP3415203B2 (en) | 1993-07-12 | 2003-06-09 | 立花 克郎 | Ultrasound generator for therapy |
JP3294387B2 (en) | 1993-07-21 | 2002-06-24 | 立花 克郎 | Ultrasonic intensity distribution measurement method |
US5405322A (en) | 1993-08-12 | 1995-04-11 | Boston Scientific Corporation | Method for treating aneurysms with a thermal source |
US5807395A (en) | 1993-08-27 | 1998-09-15 | Medtronic, Inc. | Method and apparatus for RF ablation and hyperthermia |
WO1995008289A2 (en) | 1993-09-16 | 1995-03-30 | Scimed Life Systems, Inc. | Percutaneous repair of cardiovascular anomalies and repair compositions |
US5348481A (en) | 1993-09-29 | 1994-09-20 | Cardiometrics, Inc. | Rotary connector for use with small diameter flexible elongate member having electrical capabilities |
DE4443947B4 (en) | 1994-01-14 | 2005-09-22 | Siemens Ag | endoscope |
CA2186870A1 (en) | 1994-04-01 | 1995-10-12 | Aaron V. Kaplan | Method and apparatus for performing multiple procedures |
JP3466620B2 (en) | 1994-04-07 | 2003-11-17 | デリオ・メディカル・インスツルメンツ・リミテッド | Device for removing obstruction in pipe |
US5560362A (en) | 1994-06-13 | 1996-10-01 | Acuson Corporation | Active thermal control of ultrasound transducers |
JP3394327B2 (en) | 1994-07-11 | 2003-04-07 | テルモ株式会社 | Tube inner surface treatment method |
US6113570A (en) | 1994-09-09 | 2000-09-05 | Coraje, Inc. | Method of removing thrombosis in fistulae |
JP3415286B2 (en) | 1994-09-22 | 2003-06-09 | 克郎 立花 | Ultrasonic measurement sheet |
US6689086B1 (en) | 1994-10-27 | 2004-02-10 | Advanced Cardiovascular Systems, Inc. | Method of using a catheter for delivery of ultrasonic energy and medicament |
US5569197A (en) | 1994-12-21 | 1996-10-29 | Schneider (Usa) Inc | Drug delivery guidewire |
US5724976A (en) | 1994-12-28 | 1998-03-10 | Kabushiki Kaisha Toshiba | Ultrasound imaging preferable to ultrasound contrast echography |
US5647364A (en) | 1995-02-15 | 1997-07-15 | Ultra-Scan Corporation | Ultrasonic biometric imaging and identity verification system |
US5752930A (en) | 1995-04-28 | 1998-05-19 | Medtronic, Inc. | Implantable techniques for infusing equal volumes of agents to spaced sites |
US5735280A (en) | 1995-05-02 | 1998-04-07 | Heart Rhythm Technologies, Inc. | Ultrasound energy delivery system and method |
EP0744189A1 (en) | 1995-05-26 | 1996-11-27 | Katsuro Tachibana | Medicine applying tool |
US5558092A (en) | 1995-06-06 | 1996-09-24 | Imarx Pharmaceutical Corp. | Methods and apparatus for performing diagnostic and therapeutic ultrasound simultaneously |
US5620409A (en) | 1995-09-15 | 1997-04-15 | The Research Foundation Of State University Of New York | Method for inhibiting clot formation |
US5925016A (en) | 1995-09-27 | 1999-07-20 | Xrt Corp. | Systems and methods for drug delivery including treating thrombosis by driving a drug or lytic agent through the thrombus by pressure |
US5648098A (en) | 1995-10-17 | 1997-07-15 | The Board Of Regents Of The University Of Nebraska | Thrombolytic agents and methods of treatment for thrombosis |
WO1997017018A1 (en) | 1995-11-09 | 1997-05-15 | Brigham & Women's Hospital | Aperiodic ultrasound phased array |
US5728062A (en) | 1995-11-30 | 1998-03-17 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
NL1002274C2 (en) | 1996-02-07 | 1997-08-08 | Cordis Europ | High-frequency thrombectomy catheter. |
US6033397A (en) | 1996-03-05 | 2000-03-07 | Vnus Medical Technologies, Inc. | Method and apparatus for treating esophageal varices |
US20020045890A1 (en) | 1996-04-24 | 2002-04-18 | The Regents Of The University O F California | Opto-acoustic thrombolysis |
US5938595A (en) | 1996-05-24 | 1999-08-17 | The Regents Of The University Of California | Fiber optic D dimer biosensor |
US5957851A (en) | 1996-06-10 | 1999-09-28 | Acuson Corporation | Extended bandwidth ultrasonic transducer |
US6830577B2 (en) | 1996-07-26 | 2004-12-14 | Kensey Nash Corporation | System and method of use for treating occluded vessels and diseased tissue |
US6905505B2 (en) | 1996-07-26 | 2005-06-14 | Kensey Nash Corporation | System and method of use for agent delivery and revascularizing of grafts and vessels |
US5971949A (en) | 1996-08-19 | 1999-10-26 | Angiosonics Inc. | Ultrasound transmission apparatus and method of using same |
US5984882A (en) * | 1996-08-19 | 1999-11-16 | Angiosonics Inc. | Methods for prevention and treatment of cancer and other proliferative diseases with ultrasonic energy |
US5836896A (en) | 1996-08-19 | 1998-11-17 | Angiosonics | Method of inhibiting restenosis by applying ultrasonic energy |
DE19635593C1 (en) | 1996-09-02 | 1998-04-23 | Siemens Ag | Ultrasound transducer for diagnostic and therapeutic use |
US5704105A (en) | 1996-09-04 | 1998-01-06 | General Electric Company | Method of manufacturing multilayer array ultrasonic transducers |
US5846218A (en) | 1996-09-05 | 1998-12-08 | Pharmasonics, Inc. | Balloon catheters having ultrasonically driven interface surfaces and methods for their use |
US5957941A (en) | 1996-09-27 | 1999-09-28 | Boston Scientific Corporation | Catheter system and drive assembly thereof |
US5827313A (en) | 1996-09-27 | 1998-10-27 | Boston Scientific Corporation | Device for controlled longitudinal movement of an operative element within a catheter sheath and method |
KR100219036B1 (en) * | 1996-09-30 | 1999-09-01 | 이계철 | Low voltage MOSFET controlling multiplier |
WO1998018391A1 (en) | 1996-10-30 | 1998-05-07 | Ekos Corporation | Intraluminal wall drug delivery device |
US6221038B1 (en) | 1996-11-27 | 2001-04-24 | Pharmasonics, Inc. | Apparatus and methods for vibratory intraluminal therapy employing magnetostrictive transducers |
US6110098A (en) | 1996-12-18 | 2000-08-29 | Medtronic, Inc. | System and method of mechanical treatment of cardiac fibrillation |
US5775338A (en) | 1997-01-10 | 1998-07-07 | Scimed Life Systems, Inc. | Heated perfusion balloon for reduction of restenosis |
US5846205A (en) | 1997-01-31 | 1998-12-08 | Acuson Corporation | Catheter-mounted, phased-array ultrasound transducer with improved imaging |
US5827203A (en) | 1997-04-21 | 1998-10-27 | Nita; Henry | Ultrasound system and method for myocardial revascularization |
US6676626B1 (en) | 1998-05-01 | 2004-01-13 | Ekos Corporation | Ultrasound assembly with increased efficacy |
US6582392B1 (en) | 1998-05-01 | 2003-06-24 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6723063B1 (en) | 1998-06-29 | 2004-04-20 | Ekos Corporation | Sheath for use with an ultrasound element |
WO1998048711A1 (en) | 1997-05-01 | 1998-11-05 | Ekos Corporation | Ultrasound catheter |
US5976120A (en) | 1997-05-05 | 1999-11-02 | Micro Therapeutics, Inc. | Single segment microcatheter |
US6024703A (en) | 1997-05-07 | 2000-02-15 | Eclipse Surgical Technologies, Inc. | Ultrasound device for axial ranging |
US6416740B1 (en) | 1997-05-13 | 2002-07-09 | Bristol-Myers Squibb Medical Imaging, Inc. | Acoustically active drug delivery systems |
US5842994A (en) * | 1997-07-02 | 1998-12-01 | Boston Scientific Technology, Inc. | Multifunction intraluminal ultrasound catheter having a removable core with maximized transducer aperture |
US6117101A (en) | 1997-07-08 | 2000-09-12 | The Regents Of The University Of California | Circumferential ablation device assembly |
US6108369A (en) * | 1997-07-11 | 2000-08-22 | Telefonaktiebolaget Lm Ericsson | Channelization code allocation for radio communication systems |
US6231516B1 (en) | 1997-10-14 | 2001-05-15 | Vacusense, Inc. | Endoluminal implant with therapeutic and diagnostic capability |
US5935124A (en) | 1997-12-02 | 1999-08-10 | Cordis Webster, Inc. | Tip electrode with multiple temperature sensors |
US6562021B1 (en) | 1997-12-22 | 2003-05-13 | Micrus Corporation | Variable stiffness electrically conductive composite, resistive heating catheter shaft |
US6575956B1 (en) | 1997-12-31 | 2003-06-10 | Pharmasonics, Inc. | Methods and apparatus for uniform transcutaneous therapeutic ultrasound |
AU2209599A (en) | 1997-12-31 | 1999-07-19 | Pharmasonics, Inc. | Methods and systems for the inhibition of vascular hyperplasia |
US6464680B1 (en) | 1998-07-29 | 2002-10-15 | Pharmasonics, Inc. | Ultrasonic enhancement of drug injection |
US6794369B2 (en) | 1997-12-31 | 2004-09-21 | Pharmasonics | Methods, systems, and kits for intravascular nucleic acid delivery |
US6120454A (en) | 1998-02-03 | 2000-09-19 | Boston Scientific Corporation | Annular array ultrasound catheter |
US6295990B1 (en) | 1998-02-03 | 2001-10-02 | Salient Interventional Systems, Inc. | Methods and systems for treating ischemia |
DE69838526T2 (en) | 1998-02-05 | 2008-07-03 | Biosense Webster, Inc., Diamond Bar | Device for releasing a drug in the heart |
US6089573A (en) | 1998-03-09 | 2000-07-18 | Ishikawa Gasket Co., Ltd. | Metal gasket with corrugated bead |
US6508816B2 (en) | 1998-03-27 | 2003-01-21 | John H. Shadduck | Medical instrument working end creating very high pressure gradients |
US6066123A (en) | 1998-04-09 | 2000-05-23 | The Board Of Trustees Of The Leland Stanford Junior University | Enhancement of bioavailability by use of focused energy delivery to a target tissue |
US6113546A (en) | 1998-07-31 | 2000-09-05 | Scimed Life Systems, Inc. | Off-aperture electrical connection for ultrasonic transducer |
JP3973772B2 (en) | 1998-08-28 | 2007-09-12 | 株式会社東芝 | Coal gasification combined cycle power plant |
US6312402B1 (en) | 1998-09-24 | 2001-11-06 | Ekos Corporation | Ultrasound catheter for improving blood flow to the heart |
US6135976A (en) | 1998-09-25 | 2000-10-24 | Ekos Corporation | Method, device and kit for performing gene therapy |
WO2000030554A1 (en) | 1998-11-20 | 2000-06-02 | Jones Joie P | Methods for selectively dissolving and removing materials using ultra-high frequency ultrasound |
US6607502B1 (en) | 1998-11-25 | 2003-08-19 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US6296619B1 (en) | 1998-12-30 | 2001-10-02 | Pharmasonics, Inc. | Therapeutic ultrasonic catheter for delivering a uniform energy dose |
US6165199A (en) | 1999-01-12 | 2000-12-26 | Coaxia, Inc. | Medical device for removing thromboembolic material from cerebral arteries and methods of use |
IL144513A0 (en) * | 1999-02-02 | 2002-05-23 | Transurgical Inc | Intrabody hifu applicator |
US6855123B2 (en) | 2002-08-02 | 2005-02-15 | Flow Cardia, Inc. | Therapeutic ultrasound system |
US6743196B2 (en) | 1999-03-01 | 2004-06-01 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US6231551B1 (en) | 1999-03-01 | 2001-05-15 | Coaxia, Inc. | Partial aortic occlusion devices and methods for cerebral perfusion augmentation |
US6027515A (en) | 1999-03-02 | 2000-02-22 | Sound Surgical Technologies Llc | Pulsed ultrasonic device and method |
US6726698B2 (en) | 1999-03-02 | 2004-04-27 | Sound Surgical Technologies Llc | Pulsed ultrasonic device and method |
US6398772B1 (en) | 1999-03-26 | 2002-06-04 | Coraje, Inc. | Method and apparatus for emergency treatment of patients experiencing a thrombotic vascular occlusion |
US6911026B1 (en) | 1999-07-12 | 2005-06-28 | Stereotaxis, Inc. | Magnetically guided atherectomy |
US6235024B1 (en) | 1999-06-21 | 2001-05-22 | Hosheng Tu | Catheters system having dual ablation capability |
US20010007940A1 (en) | 1999-06-21 | 2001-07-12 | Hosheng Tu | Medical device having ultrasound imaging and therapeutic means |
US6270460B1 (en) | 1999-06-24 | 2001-08-07 | Acuson Corporation | Apparatus and method to limit the life span of a diagnostic medical ultrasound probe |
US6361554B1 (en) | 1999-06-30 | 2002-03-26 | Pharmasonics, Inc. | Methods and apparatus for the subcutaneous delivery of acoustic vibrations |
IL131623A0 (en) | 1999-08-27 | 2001-01-28 | Dan Weiss | Apparatus to couple ultrasonic energy to catheters and other transdermal medical devices |
EP1214109A1 (en) | 1999-09-24 | 2002-06-19 | Omnisonics Medical Technologies, Inc. | Variable stiffness medical device |
US6196973B1 (en) | 1999-09-30 | 2001-03-06 | Siemens Medical Systems, Inc. | Flow estimation using an ultrasonically modulated contrast agent |
US20030036705A1 (en) | 1999-10-05 | 2003-02-20 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device having an impedance mismatch with rapid attachment and detachment means |
US6695781B2 (en) | 1999-10-05 | 2004-02-24 | Omnisonics Medical Technologies, Inc. | Ultrasonic medical device for tissue remodeling |
US20050096669A1 (en) | 1999-10-05 | 2005-05-05 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat coronary thrombus bearing lesions |
US6524251B2 (en) | 1999-10-05 | 2003-02-25 | Omnisonics Medical Technologies, Inc. | Ultrasonic device for tissue ablation and sheath for use therewith |
US6660013B2 (en) | 1999-10-05 | 2003-12-09 | Omnisonics Medical Technologies, Inc. | Apparatus for removing plaque from blood vessels using ultrasonic energy |
US20050043753A1 (en) * | 1999-10-05 | 2005-02-24 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat peripheral artery disease |
US20050119679A1 (en) | 1999-10-05 | 2005-06-02 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device to treat chronic total occlusions |
US20030236539A1 (en) | 1999-10-05 | 2003-12-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method for using an ultrasonic probe to clear a vascular access device |
US20040097996A1 (en) | 1999-10-05 | 2004-05-20 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using an ultrasonic medical device operating in a transverse mode |
EP1090658A1 (en) | 1999-10-05 | 2001-04-11 | OmniSonics Medical Technologies | Ultrasonic medical treatment apparatus |
US6733451B2 (en) | 1999-10-05 | 2004-05-11 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic probe used with a pharmacological agent |
US6551337B1 (en) | 1999-10-05 | 2003-04-22 | Omnisonics Medical Technologies, Inc. | Ultrasonic medical device operating in a transverse mode |
US20020077550A1 (en) | 1999-10-05 | 2002-06-20 | Rabiner Robert A. | Apparatus and method for treating gynecological diseases using an ultrasonic medical device operating in a transverse mode |
US6695782B2 (en) | 1999-10-05 | 2004-02-24 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means |
US20030065263A1 (en) | 1999-10-05 | 2003-04-03 | Omnisonics Medical Technologies, Inc. | Ultrasonic probe device with rapid attachment and detachment means having a line contact collet |
US6652547B2 (en) | 1999-10-05 | 2003-11-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method of removing occlusions using ultrasonic medical device operating in a transverse mode |
US20050043629A1 (en) | 1999-10-05 | 2005-02-24 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device having a probe with a small proximal end |
US6423026B1 (en) | 1999-12-09 | 2002-07-23 | Advanced Cardiovascular Systems, Inc. | Catheter stylet |
CN1420748A (en) | 1999-12-30 | 2003-05-28 | 珍品技术控股有限公司 | Face-lifting device |
US7166098B1 (en) | 1999-12-30 | 2007-01-23 | Advanced Cardiovascular Systems, Inc. | Medical assembly with transducer for local delivery of a therapeutic substance and method of using same |
US6663613B1 (en) | 2000-01-25 | 2003-12-16 | Bacchus Vascular, Inc. | System and methods for clot dissolution |
US6929633B2 (en) | 2000-01-25 | 2005-08-16 | Bacchus Vascular, Inc. | Apparatus and methods for clot dissolution |
US20030069525A1 (en) | 2000-03-08 | 2003-04-10 | Pharmasonics, Inc. | Methods, systems, and kits for plaque stabilization |
US6913581B2 (en) | 2000-03-20 | 2005-07-05 | Paul D. Corl | High output therapeutic ultrasound transducer |
US6508775B2 (en) * | 2000-03-20 | 2003-01-21 | Pharmasonics, Inc. | High output therapeutic ultrasound transducer |
CA2399570C (en) | 2000-03-24 | 2009-02-10 | Transurgical, Inc. | Apparatus and method for intrabody thermal treatment |
AU2001253654A1 (en) | 2000-04-27 | 2001-11-12 | Medtronic, Inc. | Vibration sensitive ablation apparatus and method |
US6506584B1 (en) | 2000-04-28 | 2003-01-14 | Battelle Memorial Institute | Apparatus and method for ultrasonic treatment of a liquid |
US20020068869A1 (en) | 2000-06-27 | 2002-06-06 | Axel Brisken | Drug delivery catheter with internal ultrasound receiver |
US6503202B1 (en) | 2000-06-29 | 2003-01-07 | Acuson Corp. | Medical diagnostic ultrasound system and method for flow analysis |
US6511478B1 (en) | 2000-06-30 | 2003-01-28 | Scimed Life Systems, Inc. | Medical probe with reduced number of temperature sensor wires |
US6366719B1 (en) | 2000-08-17 | 2002-04-02 | Miravant Systems, Inc. | Photodynamic therapy light diffuser |
US20020049395A1 (en) | 2000-08-24 | 2002-04-25 | Timi 3 | Systems for applying ultrasound energy to the thoracic cavity |
US6575922B1 (en) | 2000-10-17 | 2003-06-10 | Walnut Technologies | Ultrasound signal and temperature monitoring during sono-thrombolysis therapy |
RU2003124631A (en) | 2001-01-05 | 2005-02-27 | Бьёрн А. Дж. АНГЕЛЬСЕН (NO) АНГЕЛЬСЕН Бьёрн А. Дж. (NO) | BROADBAND CONVERTER |
US6647755B2 (en) | 2001-03-07 | 2003-11-18 | Omnisonics Medical Technologies, Inc. | Method for manufacturing small diameter medical devices |
US20020133111A1 (en) | 2001-03-19 | 2002-09-19 | Shadduck John H. | Neuro-thrombectomy catheter and method of use |
US8123789B2 (en) | 2002-04-29 | 2012-02-28 | Rohit Khanna | Central nervous system cooling catheter |
US6537224B2 (en) | 2001-06-08 | 2003-03-25 | Vermon | Multi-purpose ultrasonic slotted array transducer |
US7144381B2 (en) | 2001-06-20 | 2006-12-05 | The Regents Of The University Of California | Hemodialysis system and method |
US20030050662A1 (en) | 2001-09-07 | 2003-03-13 | Don Michael T. Anthony | Devices for observing and treating body passages |
US7141044B2 (en) | 2001-12-11 | 2006-11-28 | Ekos Corporation | Alternate site gene therapy |
US6979293B2 (en) * | 2001-12-14 | 2005-12-27 | Ekos Corporation | Blood flow reestablishment determination |
US20030135262A1 (en) | 2002-01-15 | 2003-07-17 | Dretler Stephen P. | Apparatus for piezo-electric reduction of concretions |
US6985771B2 (en) | 2002-01-22 | 2006-01-10 | Angel Medical Systems, Inc. | Rapid response system for the detection and treatment of cardiac events |
US20030163147A1 (en) | 2002-02-22 | 2003-08-28 | Rabiner Robert A. | Apparatus and method for using a vascular introducer with an ultrasonic probe |
US20040068189A1 (en) | 2002-02-28 | 2004-04-08 | Wilson Richard R. | Ultrasound catheter with embedded conductors |
ATE447889T1 (en) | 2002-03-15 | 2009-11-15 | Bjorn A J Angelsen | ULTRASONIC IMAGE OF OBJECTS IN MULTIPLE SCANNING PLANES |
US20040243062A1 (en) | 2002-06-21 | 2004-12-02 | Henry Robert E. | Trocar assembly and method |
US20040001809A1 (en) | 2002-06-26 | 2004-01-01 | Pharmasonics, Inc. | Methods and apparatus for enhancing a response to nucleic acid vaccines |
US7309334B2 (en) | 2002-07-23 | 2007-12-18 | Von Hoffmann Gerard | Intracranial aspiration catheter |
US6560837B1 (en) | 2002-07-31 | 2003-05-13 | The Gates Corporation | Assembly device for shaft damper |
US6849062B2 (en) | 2002-08-23 | 2005-02-01 | Medtronic Vascular, Inc. | Catheter having a low-friction guidewire lumen and method of manufacture |
US7335180B2 (en) | 2003-11-24 | 2008-02-26 | Flowcardia, Inc. | Steerable ultrasound catheter |
US7604608B2 (en) | 2003-01-14 | 2009-10-20 | Flowcardia, Inc. | Ultrasound catheter and methods for making and using same |
US7220233B2 (en) | 2003-04-08 | 2007-05-22 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
US7137963B2 (en) | 2002-08-26 | 2006-11-21 | Flowcardia, Inc. | Ultrasound catheter for disrupting blood vessel obstructions |
US6942620B2 (en) | 2002-09-20 | 2005-09-13 | Flowcardia Inc | Connector for securing ultrasound catheter to transducer |
US6921371B2 (en) | 2002-10-14 | 2005-07-26 | Ekos Corporation | Ultrasound radiating members for catheter |
US7077820B1 (en) | 2002-10-21 | 2006-07-18 | Advanced Medical Optics, Inc. | Enhanced microburst ultrasonic power delivery system and method |
WO2004058074A1 (en) | 2002-12-23 | 2004-07-15 | Omnisonics Medical Technologies, Inc. | Apparatus and method for ultrasonic medical device with improved visibility in imaging procedures |
US7771372B2 (en) | 2003-01-03 | 2010-08-10 | Ekos Corporation | Ultrasonic catheter with axial energy field |
EP1619995A2 (en) | 2003-04-22 | 2006-02-01 | Ekos Corporation | Ultrasound enhanced central venous catheter |
US20040220514A1 (en) | 2003-05-01 | 2004-11-04 | Medtronic Ave. | Method and system for treating vulnerable plaque |
US20040255957A1 (en) | 2003-05-01 | 2004-12-23 | Robert Cafferata | Method and system for treating vulnerable plaque |
JP2007516957A (en) | 2003-06-13 | 2007-06-28 | イマルクス セラピューティクス インコーポレーティッド | Non-invasive intravascular thrombolysis using modified ultrasound technology |
CA2535981C (en) | 2003-09-08 | 2014-10-28 | Board Of Trustees Of The University Of Arkansas | Ultrasound apparatus and method for augmented clot lysis |
US20050137520A1 (en) | 2003-10-29 | 2005-06-23 | Rule Peter R. | Catheter with ultrasound-controllable porous membrane |
EP1685800B1 (en) | 2003-11-14 | 2011-01-26 | Hitachi Medical Corporation | Thrombus detector, thrombus treating device, and methods therefor |
US20050124877A1 (en) | 2003-12-08 | 2005-06-09 | Henry Nita | Device and method for supporting placement of a therapeutic device in a blood vessel |
WO2005072391A2 (en) | 2004-01-29 | 2005-08-11 | Ekos Corporation | Small vessel ultrasound catheter |
US20050209578A1 (en) | 2004-01-29 | 2005-09-22 | Christian Evans Edward A | Ultrasonic catheter with segmented fluid delivery |
CA2553165A1 (en) | 2004-01-29 | 2005-08-11 | Ekos Corporation | Method and apparatus for detecting vascular conditions with a catheter |
US7341569B2 (en) | 2004-01-30 | 2008-03-11 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
US20050187514A1 (en) | 2004-02-09 | 2005-08-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device operating in a torsional mode |
US7794414B2 (en) | 2004-02-09 | 2010-09-14 | Emigrant Bank, N.A. | Apparatus and method for an ultrasonic medical device operating in torsional and transverse modes |
US20050192558A1 (en) | 2004-02-27 | 2005-09-01 | Chf Solutions, Inc. | Peripheral access venous cannula with infusion side holes and embedded reinforcement |
US20050216044A1 (en) | 2004-03-25 | 2005-09-29 | Hong Mun K | Total occlusion recanalization facilitating device |
US20050256410A1 (en) | 2004-05-14 | 2005-11-17 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic probe capable of bending with aid of a balloon |
EP1778091A2 (en) | 2004-06-10 | 2007-05-02 | Imarx Therapeutics, Inc. | Ultrasound device and method using same |
JP4492818B2 (en) | 2004-06-21 | 2010-06-30 | 博 古幡 | Ultrasound cerebral infarction treatment device |
US8241315B2 (en) | 2004-06-24 | 2012-08-14 | Boston Scientific Scimed, Inc. | Apparatus and method for treating occluded vasculature |
US7540852B2 (en) | 2004-08-26 | 2009-06-02 | Flowcardia, Inc. | Ultrasound catheter devices and methods |
EP1804891A4 (en) | 2004-09-15 | 2008-12-17 | Imarx Therapeutics Inc | Cavitation enhanced treatment through local delivery |
US20060069303A1 (en) | 2004-09-30 | 2006-03-30 | Couvillon Lucien A Jr | Endoscopic apparatus with integrated hemostasis device |
WO2006051542A1 (en) | 2004-11-12 | 2006-05-18 | Kpe Ltd. | Nanoparticle mediated ultrasound therapy and diagnostic imaging |
US20060184070A1 (en) | 2004-11-12 | 2006-08-17 | Hansmann Douglas R | External ultrasonic therapy |
US20060116610A1 (en) | 2004-11-30 | 2006-06-01 | Omnisonics Medical Technologies, Inc. | Apparatus and method for an ultrasonic medical device with variable frequency drive |
US20060173387A1 (en) | 2004-12-10 | 2006-08-03 | Douglas Hansmann | Externally enhanced ultrasonic therapy |
US7567016B2 (en) | 2005-02-04 | 2009-07-28 | Siemens Medical Solutions Usa, Inc. | Multi-dimensional ultrasound transducer array |
US20110160621A1 (en) | 2005-06-24 | 2011-06-30 | Henry Nita | Methods and apparatus for dissolving intracranial blood clots |
US20110313328A1 (en) | 2005-06-24 | 2011-12-22 | Penumbra, Inc. | Methods and apparatus for dissolving blockages in intracranial catheters |
US7717853B2 (en) | 2005-06-24 | 2010-05-18 | Henry Nita | Methods and apparatus for intracranial ultrasound delivery |
US20110319927A1 (en) | 2005-06-24 | 2011-12-29 | Penumbra, Inc. | Methods and apparatus for removing blood clots from intracranial aneurysms |
US20120078140A1 (en) | 2005-06-24 | 2012-03-29 | Penumbra, Inc. | Method and Apparatus for Removing Blood Clots and Tissue from the Patient's Head |
US8632560B2 (en) | 2005-08-11 | 2014-01-21 | Cook Medical Technologies Llc | System for breaking up thrombi and plaque in the vasculature |
EP1933944A2 (en) | 2005-08-30 | 2008-06-25 | Koninklijke Philips Electronics N.V. | Method of using a combination imaging and therapy transducer to dissolve blood clots |
US20070085614A1 (en) | 2005-09-06 | 2007-04-19 | Joseph Lockhart | Methods of enabling or disabling ultrasound vibration devices of ultrasound medical devices |
WO2007058668A1 (en) | 2005-11-18 | 2007-05-24 | Imarx Therapeutics, Inc. | Ultrasound apparatus and method to treat an ischemic stroke |
US9119651B2 (en) | 2006-02-13 | 2015-09-01 | Retro Vascular, Inc. | Recanalizing occluded vessels using controlled antegrade and retrograde tracking |
US9282984B2 (en) | 2006-04-05 | 2016-03-15 | Flowcardia, Inc. | Therapeutic ultrasound system |
US20080065014A1 (en) | 2006-04-21 | 2008-03-13 | Abbott Laboratories | Systems, Methods, and Devices to Facilitate Wire and Device Crossings of Obstructions in Body Lumens |
EP2015846A2 (en) | 2006-04-24 | 2009-01-21 | Ekos Corporation | Ultrasound therapy system |
US20080154181A1 (en) | 2006-05-05 | 2008-06-26 | Khanna Rohit K | Central nervous system ultrasonic drain |
US10182833B2 (en) | 2007-01-08 | 2019-01-22 | Ekos Corporation | Power parameters for ultrasonic catheter |
EP2111261B1 (en) | 2007-01-08 | 2015-04-15 | Ekos Corporation | Power parameters for ultrasonic catheter |
US20080319355A1 (en) | 2007-06-20 | 2008-12-25 | Henry Nita | Ischemic stroke therapy |
EP2494932B1 (en) | 2007-06-22 | 2020-05-20 | Ekos Corporation | Apparatus for treatment of intracranial hemorrhages |
CA2700968C (en) | 2007-09-26 | 2019-06-11 | Retro Vascular, Inc. | Recanalizing occluded vessels using radiofrequency energy |
US9283034B2 (en) | 2007-09-26 | 2016-03-15 | Retrovascular, Inc. | Recanalization system using radiofrequency energy |
US8062316B2 (en) | 2008-04-23 | 2011-11-22 | Avinger, Inc. | Catheter system and method for boring through blocked vascular passages |
US20100010393A1 (en) | 2008-07-08 | 2010-01-14 | Medtronic Vascular, Inc. | Treatment of Occlusions by External High Intensity Focused Ultrasound |
US20100063414A1 (en) | 2008-08-25 | 2010-03-11 | Ekos Corporation | Lysis Indication |
US20100063413A1 (en) | 2008-08-25 | 2010-03-11 | Ekos Corporation | Lysis Indication |
US20100210940A1 (en) | 2008-11-14 | 2010-08-19 | Hoag Memorial Hospital Presbyterian | CT-Guided Focused Ultrasound for Stroke Treatment |
US20100204582A1 (en) | 2009-02-12 | 2010-08-12 | Xuan-Ming Lu | Multidimensional, multilayer ultrasound transducer probe for medical ultrasound imaging |
US20110288449A1 (en) | 2009-03-10 | 2011-11-24 | Jan-Peter Schenkengel | Method of lysing a thrombus |
US8740835B2 (en) | 2010-02-17 | 2014-06-03 | Ekos Corporation | Treatment of vascular occlusions using ultrasonic energy and microbubbles |
EP2454998B1 (en) | 2010-08-06 | 2014-12-31 | Olympus Medical Systems Corp. | Ultrasonic diagnosis device |
US10888657B2 (en) | 2010-08-27 | 2021-01-12 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US20120197277A1 (en) | 2011-02-01 | 2012-08-02 | Stinis Curtiss T | Vascular plaque removal systems, devices, and methods |
-
1998
- 1998-06-29 US US09/107,078 patent/US6723063B1/en not_active Expired - Lifetime
-
1999
- 1999-06-29 DE DE69925122T patent/DE69925122T2/en not_active Expired - Lifetime
- 1999-06-29 JP JP2000556683A patent/JP4890674B2/en not_active Expired - Lifetime
- 1999-06-29 WO PCT/US1999/014757 patent/WO2000000095A1/en active IP Right Grant
- 1999-06-29 EP EP99932067A patent/EP1091699B1/en not_active Expired - Lifetime
-
2003
- 2003-02-18 US US10/369,270 patent/US7413556B2/en not_active Expired - Fee Related
- 2003-02-18 US US10/369,271 patent/US20040015122A1/en not_active Abandoned
-
2006
- 2006-05-03 US US11/418,491 patent/US20070112268A1/en not_active Abandoned
-
2011
- 2011-12-20 US US13/332,226 patent/US8764700B2/en not_active Expired - Fee Related
-
2014
- 2014-05-28 US US14/289,528 patent/US20140343483A1/en not_active Abandoned
Patent Citations (99)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3433226A (en) * | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
US4040414A (en) * | 1976-05-12 | 1977-08-09 | Xygiene, Inc. | Ultrasonic personal care instrument and method |
US4319580A (en) * | 1979-08-28 | 1982-03-16 | The Board Of Regents Of The University Of Washington | Method for detecting air emboli in the blood in an intracorporeal blood vessel |
US4531943A (en) * | 1983-08-08 | 1985-07-30 | Angiomedics Corporation | Catheter with soft deformable tip |
US4750902A (en) * | 1985-08-28 | 1988-06-14 | Sonomed Technology, Inc. | Endoscopic ultrasonic aspirators |
US5313949A (en) * | 1986-02-28 | 1994-05-24 | Cardiovascular Imaging Systems Incorporated | Method and apparatus for intravascular two-dimensional ultrasonography |
US4948587A (en) * | 1986-07-08 | 1990-08-14 | Massachusetts Institute Of Technology | Ultrasound enhancement of transbuccal drug delivery |
US4808153A (en) * | 1986-11-17 | 1989-02-28 | Ultramed Corporation | Device for removing plaque from arteries |
US4821740A (en) * | 1986-11-26 | 1989-04-18 | Shunro Tachibana | Endermic application kits for external medicines |
US4953565A (en) * | 1986-11-26 | 1990-09-04 | Shunro Tachibana | Endermic application kits for external medicines |
US5421338A (en) * | 1988-03-21 | 1995-06-06 | Boston Scientific Corporation | Acoustic imaging catheter and the like |
US4924863A (en) * | 1988-05-04 | 1990-05-15 | Mmtc, Inc. | Angioplastic method for removing plaque from a vas |
US5344435A (en) * | 1988-07-28 | 1994-09-06 | Bsd Medical Corporation | Urethral inserted applicator prostate hyperthermia |
US4920954A (en) * | 1988-08-05 | 1990-05-01 | Sonic Needle Corporation | Ultrasonic device for applying cavitation forces |
US5021044A (en) * | 1989-01-30 | 1991-06-04 | Advanced Cardiovascular Systems, Inc. | Catheter for even distribution of therapeutic fluids |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US4936281A (en) * | 1989-04-13 | 1990-06-26 | Everest Medical Corporation | Ultrasonically enhanced RF ablation catheter |
US5344395A (en) * | 1989-11-13 | 1994-09-06 | Scimed Life Systems, Inc. | Apparatus for intravascular cavitation or delivery of low frequency mechanical energy |
US5323769A (en) * | 1990-02-23 | 1994-06-28 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
US5108369A (en) * | 1990-03-15 | 1992-04-28 | Diagnostic Devices Group, Limited | Dual-diameter multifunction catheter |
US5282785A (en) * | 1990-06-15 | 1994-02-01 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5498238A (en) * | 1990-06-15 | 1996-03-12 | Cortrak Medical, Inc. | Simultaneous angioplasty and phoretic drug delivery |
US5286254A (en) * | 1990-06-15 | 1994-02-15 | Cortrak Medical, Inc. | Drug delivery apparatus and method |
US5628730A (en) * | 1990-06-15 | 1997-05-13 | Cortrak Medical, Inc. | Phoretic balloon catheter with hydrogel coating |
US5197946A (en) * | 1990-06-27 | 1993-03-30 | Shunro Tachibana | Injection instrument with ultrasonic oscillating element |
US5520189A (en) * | 1990-07-13 | 1996-05-28 | Coraje, Inc. | Intravascular ultrasound imaging guidewire |
US5431663A (en) * | 1990-12-10 | 1995-07-11 | Coraje, Inc. | Miniature ultrasonic transducer for removal of intravascular plaque and clots |
US5916192A (en) * | 1991-01-11 | 1999-06-29 | Advanced Cardiovascular Systems, Inc. | Ultrasonic angioplasty-atherectomy catheter and method of use |
US5304115A (en) * | 1991-01-11 | 1994-04-19 | Baxter International Inc. | Ultrasonic angioplasty device incorporating improved transmission member and ablation probe |
US5445155A (en) * | 1991-03-13 | 1995-08-29 | Scimed Life Systems Incorporated | Intravascular imaging apparatus and methods for use and manufacture |
US5307816A (en) * | 1991-08-21 | 1994-05-03 | Kabushiki Kaisha Toshiba | Thrombus resolving treatment apparatus |
US5345940A (en) * | 1991-11-08 | 1994-09-13 | Mayo Foundation For Medical Education And Research | Transvascular ultrasound hemodynamic and interventional catheter and method |
US5713831A (en) * | 1992-02-17 | 1998-02-03 | Olsson; Sten Bertil | Method and apparatus for arterial reperfusion through noninvasive ultrasonic action |
US5226421A (en) * | 1992-03-06 | 1993-07-13 | Cardiometrics, Inc. | Doppler elongate flexible member having an inflatable balloon mounted thereon |
US5295484A (en) * | 1992-05-19 | 1994-03-22 | Arizona Board Of Regents For And On Behalf Of The University Of Arizona | Apparatus and method for intra-cardiac ablation of arrhythmias |
US5380273A (en) * | 1992-05-19 | 1995-01-10 | Dubrul; Will R. | Vibrating catheter |
US5327891A (en) * | 1992-07-30 | 1994-07-12 | Rammler David H | Catheter track and catheter for diagnosis and treatment |
US5318014A (en) * | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
US5523058A (en) * | 1992-09-16 | 1996-06-04 | Hitachi, Ltd. | Ultrasonic irradiation apparatus and processing apparatus based thereon |
US5617851A (en) * | 1992-10-14 | 1997-04-08 | Endodermic Medical Technologies Company | Ultrasonic transdermal system for withdrawing fluid from an organism and determining the concentration of a substance in the fluid |
US5620479A (en) * | 1992-11-13 | 1997-04-15 | The Regents Of The University Of California | Method and apparatus for thermal therapy of tumors |
US5397293A (en) * | 1992-11-25 | 1995-03-14 | Misonix, Inc. | Ultrasonic device with sheath and transverse motion damping |
US5603327A (en) * | 1993-02-01 | 1997-02-18 | Endosonics Corporation | Ultrasound catheter probe |
US5713848A (en) * | 1993-05-19 | 1998-02-03 | Dubrul; Will R. | Vibrating catheter |
US5630837A (en) * | 1993-07-01 | 1997-05-20 | Boston Scientific Corporation | Acoustic ablation |
US5385148A (en) * | 1993-07-30 | 1995-01-31 | The Regents Of The University Of California | Cardiac imaging and ablation catheter |
US5660182A (en) * | 1993-09-20 | 1997-08-26 | Colin Corporation | Inflatable cuff used for blood pressure measurement and automatic blood pressure measuring apparatus including inflatable cuff |
US5390678A (en) * | 1993-10-12 | 1995-02-21 | Baxter International Inc. | Method and device for measuring ultrasonic activity in an ultrasound delivery system |
US5533986A (en) * | 1994-02-18 | 1996-07-09 | Merit Medical Systems, Inc. | Catheter apparatus with means for subcutaneous delivery of anesthetic agent or other fluid medicament |
US6110314A (en) * | 1994-03-11 | 2000-08-29 | Intravascular Research Limited | Ultrasonic transducer array and method of manufacturing the same |
US6238347B1 (en) * | 1994-03-11 | 2001-05-29 | Intravascular Research Limited | Ultrasonic transducer array and method of manufacturing the same |
US5772632A (en) * | 1994-04-13 | 1998-06-30 | Schneider (Usa) Inc. | Dilation-drug delivery catheter |
US5423797A (en) * | 1994-04-25 | 1995-06-13 | Medelex, Inc. | Acoustic catheter with rotary drive |
US5514092A (en) * | 1994-08-08 | 1996-05-07 | Schneider (Usa) Inc. | Drug delivery and dilatation-drug delivery catheters in a rapid exchange configuration |
US5509896A (en) * | 1994-09-09 | 1996-04-23 | Coraje, Inc. | Enhancement of thrombolysis with external ultrasound |
US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US5606974A (en) * | 1995-05-02 | 1997-03-04 | Heart Rhythm Technologies, Inc. | Catheter having ultrasonic device |
US5628728A (en) * | 1995-05-31 | 1997-05-13 | Ekos Corporation | Medicine applying tool |
US5779673A (en) * | 1995-06-26 | 1998-07-14 | Focal, Inc. | Devices and methods for application of intraluminal photopolymerized gels |
US5603694A (en) * | 1995-10-17 | 1997-02-18 | Brown; Joe E. | Infusion coil apparatus and method for delivering fluid-based agents intravascularly |
US5618275A (en) * | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
US5735811A (en) * | 1995-11-30 | 1998-04-07 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced fluid delivery |
US5725494A (en) * | 1995-11-30 | 1998-03-10 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced intraluminal therapy |
US5941868A (en) * | 1995-12-22 | 1999-08-24 | Localmed, Inc. | Localized intravascular delivery of growth factors for promotion of angiogenesis |
US5656016A (en) * | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
US6024718A (en) * | 1996-09-04 | 2000-02-15 | The Regents Of The University Of California | Intraluminal directed ultrasound delivery device |
US5876345A (en) * | 1997-02-27 | 1999-03-02 | Acuson Corporation | Ultrasonic catheter, system and method for two dimensional imaging or three-dimensional reconstruction |
US6053868A (en) * | 1997-04-24 | 2000-04-25 | Sulzer Osypka Gmbh | Apparatus for a cardiological therapy |
US6063069A (en) * | 1997-05-19 | 2000-05-16 | Micro Therapeutics Inc. | Method and apparatus for power lysis of a thrombus |
US6228046B1 (en) * | 1997-06-02 | 2001-05-08 | Pharmasonics, Inc. | Catheters comprising a plurality of oscillators and methods for their use |
US5931805A (en) * | 1997-06-02 | 1999-08-03 | Pharmasonics, Inc. | Catheters comprising bending transducers and methods for their use |
US6379320B1 (en) * | 1997-06-11 | 2002-04-30 | Institut National De La Santa Et De La Recherche Medicale I.N.S.E.R.M. | Ultrasound applicator for heating an ultrasound absorbent medium |
US6096000A (en) * | 1997-06-23 | 2000-08-01 | Ekos Corporation | Apparatus for transport of fluids across, into or from biological tissues |
US6078830A (en) * | 1997-10-01 | 2000-06-20 | Ep Technologies, Inc. | Molded catheter distal end assembly and process for the manufacture thereof |
US6585763B1 (en) * | 1997-10-14 | 2003-07-01 | Vascusense, Inc. | Implantable therapeutic device and method |
US6372498B2 (en) * | 1997-12-31 | 2002-04-16 | Pharmasonics, Inc. | Methods, systems, and kits for intravascular nucleic acid delivery |
US6561998B1 (en) * | 1998-04-07 | 2003-05-13 | Transvascular, Inc. | Transluminal devices, systems and methods for enlarging interstitial penetration tracts |
US6210356B1 (en) * | 1998-08-05 | 2001-04-03 | Ekos Corporation | Ultrasound assembly for use with a catheter |
US6059731A (en) * | 1998-08-19 | 2000-05-09 | Mayo Foundation For Medical Education And Research | Simultaneous side-and-end viewing underfluid catheter |
US6277077B1 (en) * | 1998-11-16 | 2001-08-21 | Cardiac Pathways Corporation | Catheter including ultrasound transducer with emissions attenuation |
US6206831B1 (en) * | 1999-01-06 | 2001-03-27 | Scimed Life Systems, Inc. | Ultrasound-guided ablation catheter and methods of use |
US20010000791A1 (en) * | 1999-01-06 | 2001-05-03 | Suorsa Veijo T. | Ultrasound-guided ablation catheter and methods of use |
US6579279B1 (en) * | 1999-09-24 | 2003-06-17 | Omnisonics Medical Technologies, Inc. | Steerable catheter device |
US6542767B1 (en) * | 1999-11-09 | 2003-04-01 | Biotex, Inc. | Method and system for controlling heat delivery to a target |
US6524300B2 (en) * | 2000-01-03 | 2003-02-25 | Angiodynamics, Inc. | Infusion catheter with non-uniform drug delivery density |
US6361500B1 (en) * | 2000-02-07 | 2002-03-26 | Scimed Life Systems, Inc. | Three transducer catheter |
US20020032394A1 (en) * | 2000-03-08 | 2002-03-14 | Axel Brisken | Methods, systems, and kits for plaque stabilization |
US6599288B2 (en) * | 2000-05-16 | 2003-07-29 | Atrionix, Inc. | Apparatus and method incorporating an ultrasound transducer onto a delivery member |
US7089063B2 (en) * | 2000-05-16 | 2006-08-08 | Atrionix, Inc. | Deflectable tip catheter with guidewire tracking mechanism |
US6711953B2 (en) * | 2000-08-25 | 2004-03-30 | Furuno Electric Company, Ltd. | Method of and apparatus for controlling beams produced by a cylindrical transducer |
US6758857B2 (en) * | 2000-11-13 | 2004-07-06 | Acmi Corporation | Treatment catheters with thermally insulated regions |
US6740040B1 (en) * | 2001-01-30 | 2004-05-25 | Advanced Cardiovascular Systems, Inc. | Ultrasound energy driven intraventricular catheter to treat ischemia |
US6589182B1 (en) * | 2001-02-12 | 2003-07-08 | Acuson Corporation | Medical diagnostic ultrasound catheter with first and second tip portions |
US6437487B1 (en) * | 2001-02-28 | 2002-08-20 | Acuson Corporation | Transducer array using multi-layered elements and a method of manufacture thereof |
US20040019318A1 (en) * | 2001-11-07 | 2004-01-29 | Wilson Richard R. | Ultrasound assembly for use with a catheter |
US20040024347A1 (en) * | 2001-12-03 | 2004-02-05 | Wilson Richard R. | Catheter with multiple ultrasound radiating members |
US20040049148A1 (en) * | 2001-12-03 | 2004-03-11 | Oscar Rodriguez | Small vessel ultrasound catheter |
US20040024393A1 (en) * | 2002-08-02 | 2004-02-05 | Henry Nita | Therapeutic ultrasound system |
US20050004373A1 (en) * | 2003-07-04 | 2005-01-06 | Kumar Bobba Venkata Siva | Process for the preparation of 4,4-dimethyl-6-ethynylthiochroman |
Cited By (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9415242B2 (en) | 2001-12-03 | 2016-08-16 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10080878B2 (en) | 2001-12-03 | 2018-09-25 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US10926074B2 (en) | 2001-12-03 | 2021-02-23 | Ekos Corporation | Catheter with multiple ultrasound radiating members |
US7771372B2 (en) | 2003-01-03 | 2010-08-10 | Ekos Corporation | Ultrasonic catheter with axial energy field |
US20040199228A1 (en) * | 2003-01-03 | 2004-10-07 | Wilson Richard R. | Ultrasonic catheter with axial energy field |
US11925367B2 (en) | 2007-01-08 | 2024-03-12 | Ekos Corporation | Power parameters for ultrasonic catheter |
US11672553B2 (en) | 2007-06-22 | 2023-06-13 | Ekos Corporation | Method and apparatus for treatment of intracranial hemorrhages |
US10363103B2 (en) | 2009-04-29 | 2019-07-30 | Auris Health, Inc. | Flexible and steerable elongate instruments with shape control and support elements |
US11464586B2 (en) | 2009-04-29 | 2022-10-11 | Auris Health, Inc. | Flexible and steerable elongate instruments with shape control and support elements |
US11213356B2 (en) | 2010-09-17 | 2022-01-04 | Auris Health, Inc. | Systems and methods for positioning an elongate member inside a body |
US10555780B2 (en) | 2010-09-17 | 2020-02-11 | Auris Health, Inc. | Systems and methods for positioning an elongate member inside a body |
US10130427B2 (en) | 2010-09-17 | 2018-11-20 | Auris Health, Inc. | Systems and methods for positioning an elongate member inside a body |
US11458290B2 (en) | 2011-05-11 | 2022-10-04 | Ekos Corporation | Ultrasound system |
US11419518B2 (en) | 2011-07-29 | 2022-08-23 | Auris Health, Inc. | Apparatus and methods for fiber integration and registration |
US10667720B2 (en) | 2011-07-29 | 2020-06-02 | Auris Health, Inc. | Apparatus and methods for fiber integration and registration |
US10080576B2 (en) | 2013-03-08 | 2018-09-25 | Auris Health, Inc. | Method, apparatus, and a system for facilitating bending of an instrument in a surgical or medical robotic environment |
US10149720B2 (en) | 2013-03-08 | 2018-12-11 | Auris Health, Inc. | Method, apparatus, and a system for facilitating bending of an instrument in a surgical or medical robotic environment |
US11723636B2 (en) | 2013-03-08 | 2023-08-15 | Auris Health, Inc. | Method, apparatus, and system for facilitating bending of an instrument in a surgical or medical robotic environment |
US11413428B2 (en) | 2013-03-15 | 2022-08-16 | Auris Health, Inc. | Catheter insertion system and method of fabrication |
US10376672B2 (en) | 2013-03-15 | 2019-08-13 | Auris Health, Inc. | Catheter insertion system and method of fabrication |
US10405939B2 (en) | 2013-10-24 | 2019-09-10 | Auris Health, Inc. | Endoscopic device with helical lumen design |
US10405940B2 (en) | 2013-10-24 | 2019-09-10 | Auris Health, Inc. | Endoscopic device with double-helical lumen design |
US11511079B2 (en) | 2014-07-01 | 2022-11-29 | Auris Health, Inc. | Apparatuses and methods for monitoring tendons of steerable catheters |
US10814101B2 (en) | 2014-07-01 | 2020-10-27 | Auris Health, Inc. | Apparatuses and methods for monitoring tendons of steerable catheters |
US20160001038A1 (en) * | 2014-07-01 | 2016-01-07 | Auris Surgical Robotics, Inc. | Tool and method for using surgical endoscope with spiral lumens |
US11759605B2 (en) | 2014-07-01 | 2023-09-19 | Auris Health, Inc. | Tool and method for using surgical endoscope with spiral lumens |
US10792464B2 (en) * | 2014-07-01 | 2020-10-06 | Auris Health, Inc. | Tool and method for using surgical endoscope with spiral lumens |
US11350998B2 (en) | 2014-07-01 | 2022-06-07 | Auris Health, Inc. | Medical instrument having translatable spool |
US10493241B2 (en) | 2014-07-01 | 2019-12-03 | Auris Health, Inc. | Apparatuses and methods for monitoring tendons of steerable catheters |
US10398518B2 (en) | 2014-07-01 | 2019-09-03 | Auris Health, Inc. | Articulating flexible endoscopic tool with roll capabilities |
US10092742B2 (en) | 2014-09-22 | 2018-10-09 | Ekos Corporation | Catheter system |
US10507320B2 (en) | 2014-09-22 | 2019-12-17 | Ekos Corporation | Catheter system |
US11819636B2 (en) | 2015-03-30 | 2023-11-21 | Auris Health, Inc. | Endoscope pull wire electrical circuit |
US10656025B2 (en) | 2015-06-10 | 2020-05-19 | Ekos Corporation | Ultrasound catheter |
US11740138B2 (en) | 2015-06-10 | 2023-08-29 | Ekos Corporation | Ultrasound catheter |
US10463439B2 (en) | 2016-08-26 | 2019-11-05 | Auris Health, Inc. | Steerable catheter with shaft load distributions |
US11701192B2 (en) | 2016-08-26 | 2023-07-18 | Auris Health, Inc. | Steerable catheter with shaft load distributions |
US10716461B2 (en) | 2017-05-17 | 2020-07-21 | Auris Health, Inc. | Exchangeable working channel |
US11730351B2 (en) | 2017-05-17 | 2023-08-22 | Auris Health, Inc. | Exchangeable working channel |
US11109920B2 (en) | 2018-03-28 | 2021-09-07 | Auris Health, Inc. | Medical instruments with variable bending stiffness profiles |
US11779400B2 (en) | 2018-08-07 | 2023-10-10 | Auris Health, Inc. | Combining strain-based shape sensing with catheter control |
US10898276B2 (en) | 2018-08-07 | 2021-01-26 | Auris Health, Inc. | Combining strain-based shape sensing with catheter control |
US11779421B2 (en) | 2018-09-26 | 2023-10-10 | Auris Health, Inc. | Articulating medical instruments |
US11179212B2 (en) | 2018-09-26 | 2021-11-23 | Auris Health, Inc. | Articulating medical instruments |
US11986257B2 (en) | 2018-12-28 | 2024-05-21 | Auris Health, Inc. | Medical instrument with articulable segment |
US11617627B2 (en) | 2019-03-29 | 2023-04-04 | Auris Health, Inc. | Systems and methods for optical strain sensing in medical instruments |
US11717147B2 (en) | 2019-08-15 | 2023-08-08 | Auris Health, Inc. | Medical device having multiple bending sections |
US11950872B2 (en) | 2019-12-31 | 2024-04-09 | Auris Health, Inc. | Dynamic pulley system |
Also Published As
Publication number | Publication date |
---|---|
US20070112268A1 (en) | 2007-05-17 |
US7413556B2 (en) | 2008-08-19 |
JP4890674B2 (en) | 2012-03-07 |
DE69925122D1 (en) | 2005-06-09 |
US8764700B2 (en) | 2014-07-01 |
US20120089082A1 (en) | 2012-04-12 |
US20030216681A1 (en) | 2003-11-20 |
EP1091699A1 (en) | 2001-04-18 |
US20140343483A1 (en) | 2014-11-20 |
US6723063B1 (en) | 2004-04-20 |
DE69925122T2 (en) | 2006-01-19 |
WO2000000095A1 (en) | 2000-01-06 |
JP2002519095A (en) | 2002-07-02 |
EP1091699B1 (en) | 2005-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8764700B2 (en) | Sheath for use with an ultrasound element | |
US11672553B2 (en) | Method and apparatus for treatment of intracranial hemorrhages | |
US20210178140A1 (en) | Catheter with multiple ultrasound radiating members | |
US6001069A (en) | Ultrasound catheter for providing a therapeutic effect to a vessel of a body | |
US8690818B2 (en) | Ultrasound catheter for providing a therapeutic effect to a vessel of a body | |
US6921371B2 (en) | Ultrasound radiating members for catheter | |
US20050209578A1 (en) | Ultrasonic catheter with segmented fluid delivery | |
US20040019318A1 (en) | Ultrasound assembly for use with a catheter | |
US7201737B2 (en) | Treatment of vascular occlusions using elevated temperatures |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: HERCULES TECHNOLOGY II, L.P., CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:EKOS CORPORATION;REEL/FRAME:019550/0881 Effective date: 20070524 Owner name: HERCULES TECHNOLOGY II, L.P.,CALIFORNIA Free format text: SECURITY AGREEMENT;ASSIGNOR:EKOS CORPORATION;REEL/FRAME:019550/0881 Effective date: 20070524 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |
|
AS | Assignment |
Owner name: EKOS CORPORATION, WASHINGTON Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:HERCULES TECHNOLOGY II, L.P.;REEL/FRAME:030421/0867 Effective date: 20101021 |
|
AS | Assignment |
Owner name: EKOS LLC, WASHINGTON Free format text: CHANGE OF NAME;ASSIGNOR:EKOS CORPORATION;REEL/FRAME:067043/0077 Effective date: 20191209 Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:EKOS LLC;REEL/FRAME:067042/0823 Effective date: 20191231 Owner name: EKOS CORPORATION, WASHINGTON Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ZHANG, JOHN;LICHTTENEGGER, GARY;RODRIGUEY, JAMES E.;AND OTHERS;SIGNING DATES FROM 19980917 TO 19980922;REEL/FRAME:067042/0668 |